Exam 3: Biology

arrow
  • Select Tags
search iconSearch Question
flashcardsStudy Flashcards
  • Select Tags

Passage Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common heterogeneous disorders, with a reported incidence of 1 in 1,000 people.  The primary pathology is the development of numerous fluid-filled renal cysts that ultimately expand and severely impair kidney function.  By age 60, approximately 50% of patients with ADPKD progress to end-stage renal disease (ESRD) and kidney failure.  Clinical complications include high blood pressure, urinary tract infections, and cysts in other organs such as the liver and pancreas.Approximately 85% of ADPKD cases are caused by mutations in the PKD1 gene, which codes for the protein polycystin-1 (PC1).  The remaining 15% of cases are caused by mutations in the PKD2 gene, which codes for the protein polycystin-2 (PC2).  The PC2 protein functions as a mechanically activated calcium (Ca2+) channel in ciliated renal epithelial cells.  PC1 and PC2 interact via their C-terminal cytoplasmic tails to form a heteromer that modulates intracellular calcium homeostasis.  Disruption of calcium signaling as a result of mutations in either PKD1 or PKD2 is associated with increased cell growth and cyst formation in ADPKD patients.To identify individuals with mutations in PKD1 and PKD2, researchers analyzed phenotypic and genetic data from patients with established renal disease, as shown in Table 1.Table 1  Comparison of Renal Disease Onset and Symptom Severity in Various Patient Groups Passage Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common heterogeneous disorders, with a reported incidence of 1 in 1,000 people.  The primary pathology is the development of numerous fluid-filled renal cysts that ultimately expand and severely impair kidney function.  By age 60, approximately 50% of patients with ADPKD progress to end-stage renal disease (ESRD) and kidney failure.  Clinical complications include high blood pressure, urinary tract infections, and cysts in other organs such as the liver and pancreas.Approximately 85% of ADPKD cases are caused by mutations in the PKD1 gene, which codes for the protein polycystin-1 (PC1).  The remaining 15% of cases are caused by mutations in the PKD2 gene, which codes for the protein polycystin-2 (PC2).  The PC2 protein functions as a mechanically activated calcium (Ca<sup>2+</sup>) channel in ciliated renal epithelial cells.  PC1 and PC2 interact via their C-terminal cytoplasmic tails to form a heteromer that modulates intracellular calcium homeostasis.  Disruption of calcium signaling as a result of mutations in either PKD1 or PKD2 is associated with increased cell growth and cyst formation in ADPKD patients.To identify individuals with mutations in PKD1 and PKD2, researchers analyzed phenotypic and genetic data from patients with established renal disease, as shown in Table 1.<strong>Table 1</strong>  Comparison of Renal Disease Onset and Symptom Severity in Various Patient Groups    Next, researchers examined how phenotypic disease severity was affected by both the position of the mutations in PKD1 (5′ or 3′ end) and the type of mutation in PKD1 or PKD2.  In Figure 1, disease severity is given as the cumulative probability of renal survival as a function of age.    <strong>Figure 1</strong>  Probability of maintaining healthy kidney physiology as a function of age, analyzed by mutation type and position Adapted from Cornec-le gall E, Audrézet MP, Chen JM, et al. J Am Soc Nephrol. 2013;24(6):1006-13. -Which of the following DNA mutations would always lead to truncated PC1 if observed in the coding strand of the PKD1 gene shown below?  Next, researchers examined how phenotypic disease severity was affected by both the position of the mutations in PKD1 (5′ or 3′ end) and the type of mutation in PKD1 or PKD2.  In Figure 1, disease severity is given as the cumulative probability of renal survival as a function of age. Passage Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common heterogeneous disorders, with a reported incidence of 1 in 1,000 people.  The primary pathology is the development of numerous fluid-filled renal cysts that ultimately expand and severely impair kidney function.  By age 60, approximately 50% of patients with ADPKD progress to end-stage renal disease (ESRD) and kidney failure.  Clinical complications include high blood pressure, urinary tract infections, and cysts in other organs such as the liver and pancreas.Approximately 85% of ADPKD cases are caused by mutations in the PKD1 gene, which codes for the protein polycystin-1 (PC1).  The remaining 15% of cases are caused by mutations in the PKD2 gene, which codes for the protein polycystin-2 (PC2).  The PC2 protein functions as a mechanically activated calcium (Ca<sup>2+</sup>) channel in ciliated renal epithelial cells.  PC1 and PC2 interact via their C-terminal cytoplasmic tails to form a heteromer that modulates intracellular calcium homeostasis.  Disruption of calcium signaling as a result of mutations in either PKD1 or PKD2 is associated with increased cell growth and cyst formation in ADPKD patients.To identify individuals with mutations in PKD1 and PKD2, researchers analyzed phenotypic and genetic data from patients with established renal disease, as shown in Table 1.<strong>Table 1</strong>  Comparison of Renal Disease Onset and Symptom Severity in Various Patient Groups    Next, researchers examined how phenotypic disease severity was affected by both the position of the mutations in PKD1 (5′ or 3′ end) and the type of mutation in PKD1 or PKD2.  In Figure 1, disease severity is given as the cumulative probability of renal survival as a function of age.    <strong>Figure 1</strong>  Probability of maintaining healthy kidney physiology as a function of age, analyzed by mutation type and position Adapted from Cornec-le gall E, Audrézet MP, Chen JM, et al. J Am Soc Nephrol. 2013;24(6):1006-13. -Which of the following DNA mutations would always lead to truncated PC1 if observed in the coding strand of the PKD1 gene shown below?  Figure 1  Probability of maintaining healthy kidney physiology as a function of age, analyzed by mutation type and position Adapted from Cornec-le gall E, Audrézet MP, Chen JM, et al. J Am Soc Nephrol. 2013;24(6):1006-13. -Which of the following DNA mutations would always lead to truncated PC1 if observed in the coding strand of the PKD1 gene shown below? Passage Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common heterogeneous disorders, with a reported incidence of 1 in 1,000 people.  The primary pathology is the development of numerous fluid-filled renal cysts that ultimately expand and severely impair kidney function.  By age 60, approximately 50% of patients with ADPKD progress to end-stage renal disease (ESRD) and kidney failure.  Clinical complications include high blood pressure, urinary tract infections, and cysts in other organs such as the liver and pancreas.Approximately 85% of ADPKD cases are caused by mutations in the PKD1 gene, which codes for the protein polycystin-1 (PC1).  The remaining 15% of cases are caused by mutations in the PKD2 gene, which codes for the protein polycystin-2 (PC2).  The PC2 protein functions as a mechanically activated calcium (Ca<sup>2+</sup>) channel in ciliated renal epithelial cells.  PC1 and PC2 interact via their C-terminal cytoplasmic tails to form a heteromer that modulates intracellular calcium homeostasis.  Disruption of calcium signaling as a result of mutations in either PKD1 or PKD2 is associated with increased cell growth and cyst formation in ADPKD patients.To identify individuals with mutations in PKD1 and PKD2, researchers analyzed phenotypic and genetic data from patients with established renal disease, as shown in Table 1.<strong>Table 1</strong>  Comparison of Renal Disease Onset and Symptom Severity in Various Patient Groups    Next, researchers examined how phenotypic disease severity was affected by both the position of the mutations in PKD1 (5′ or 3′ end) and the type of mutation in PKD1 or PKD2.  In Figure 1, disease severity is given as the cumulative probability of renal survival as a function of age.    <strong>Figure 1</strong>  Probability of maintaining healthy kidney physiology as a function of age, analyzed by mutation type and position Adapted from Cornec-le gall E, Audrézet MP, Chen JM, et al. J Am Soc Nephrol. 2013;24(6):1006-13. -Which of the following DNA mutations would always lead to truncated PC1 if observed in the coding strand of the PKD1 gene shown below?

(Multiple Choice)
4.9/5
(97)

Passage Alzheimer disease (AD) is a progressive condition affecting memory and cognition that can be pathologically characterized by the presence of neurofibrillary tangles (NFTs).  NFTs, aggregates of hyperphosphorylated tau proteins that have dissociated from microtubules, are believed to contribute to neuronal degradation and subsequent AD symptoms.  In general, ribosomes initiate translation of tau mRNA by binding the 7-methylguanosine (m7Gpp) cap present at the end of the 5′ untranslated region (UTR) of the mRNA molecule.  However, researchers believe that tau protein translation initiation can occur without recognition of the m7Gpp cap.  This alternate mechanism, referred to as cap-independent translation, indicates that ribosomes are recruited by internal ribosome entry sites (IRES) generally located in the 5′ UTR of the mRNA sequence.To determine the initiation mechanism of tau mRNA translation, neuroblastoma cells of AD mice were transfected with two different DNA constructs (Figure 1).  Construct 1 contained the 5′ UTR of tau mRNA isoforms (v1 and v2) extracted from cells displaying NFTs.  Construct 2 included the 5′ UTR of the β-globulin gene, which normally codes for a plasma protein.  The luciferase reporter genes, Renillla and Photinus, were also included in the two constructs. /_ /_ Passage Alzheimer disease (AD) is a progressive condition affecting memory and cognition that can be pathologically characterized by the presence of neurofibrillary tangles (NFTs).  NFTs, aggregates of hyperphosphorylated tau proteins that have dissociated from microtubules, are believed to contribute to neuronal degradation and subsequent AD symptoms.  In general, ribosomes initiate translation of tau mRNA by binding the 7-methylguanosine (m7Gpp) cap present at the end of the 5′ untranslated region (UTR) of the mRNA molecule.  However, researchers believe that tau protein translation initiation can occur without recognition of the m7Gpp cap.  This alternate mechanism, referred to as cap-independent translation, indicates that ribosomes are recruited by internal ribosome entry sites (IRES) generally located in the 5′ UTR of the mRNA sequence.To determine the initiation mechanism of tau mRNA translation, neuroblastoma cells of AD mice were transfected with two different DNA constructs (Figure 1).  Construct 1 contained the 5′ UTR of tau mRNA isoforms (v1 and v2) extracted from cells displaying NFTs.  Construct 2 included the 5′ UTR of the β-globulin gene, which normally codes for a plasma protein.  The luciferase reporter genes, Renillla and Photinus, were also included in the two constructs. /_ /_    <strong>Figure 1</strong>  DNA constructs containing β-globulin or tau gene used to transfect neuroblastoma cellsLuciferase gene expression from the constructs was monitored in the absence and presence of a synthetic m7Gpp cap analog (Figure 2).  Translation of Renillla luciferase mRNA depended on ribosomal binding to the m7Gpp cap of the mRNA, but translation of Photinus luciferase required ribosome recruitment by an IRES in the 5′ UTR of the adjacent gene.    <strong>Figure 2</strong>  Luciferase activity in neuroblastoma cells exposed to m7Gpp cap analogIn a second study, researchers used siRNA to target initiation factor eIF4E, a peptide translated in a cap-dependent manner that facilitates the binding of ribosomes to the m7Gpp cap.  Expression of factor eIF4E, elongation factor eEF2K, and tau v2 protein was assessed in siRNA-treated cells (Figure 3).    <strong>Figure 3</strong>  Western blot of eIF4E, eEF2K, and tau v2 extracted from non-AD cells treated with eIF4E siRNA Adapted from Veo BL, Krushel LA. Translation initiation of the human tau mRNA through an internal ribosomal entry site. J Alzheimers Dis. 2009; 16(2):271-5. -Assume gene expression of tau v1 and v2 are synchronized in AD mice cells, and tau mRNA levels are analyzed.  Of the following, which technique would researchers use to identify the tau mRNA isoform with the longer half-life in the cytoplasm of AD mice cells? Figure 1  DNA constructs containing β-globulin or tau gene used to transfect neuroblastoma cellsLuciferase gene expression from the constructs was monitored in the absence and presence of a synthetic m7Gpp cap analog (Figure 2).  Translation of Renillla luciferase mRNA depended on ribosomal binding to the m7Gpp cap of the mRNA, but translation of Photinus luciferase required ribosome recruitment by an IRES in the 5′ UTR of the adjacent gene. Passage Alzheimer disease (AD) is a progressive condition affecting memory and cognition that can be pathologically characterized by the presence of neurofibrillary tangles (NFTs).  NFTs, aggregates of hyperphosphorylated tau proteins that have dissociated from microtubules, are believed to contribute to neuronal degradation and subsequent AD symptoms.  In general, ribosomes initiate translation of tau mRNA by binding the 7-methylguanosine (m7Gpp) cap present at the end of the 5′ untranslated region (UTR) of the mRNA molecule.  However, researchers believe that tau protein translation initiation can occur without recognition of the m7Gpp cap.  This alternate mechanism, referred to as cap-independent translation, indicates that ribosomes are recruited by internal ribosome entry sites (IRES) generally located in the 5′ UTR of the mRNA sequence.To determine the initiation mechanism of tau mRNA translation, neuroblastoma cells of AD mice were transfected with two different DNA constructs (Figure 1).  Construct 1 contained the 5′ UTR of tau mRNA isoforms (v1 and v2) extracted from cells displaying NFTs.  Construct 2 included the 5′ UTR of the β-globulin gene, which normally codes for a plasma protein.  The luciferase reporter genes, Renillla and Photinus, were also included in the two constructs. /_ /_    <strong>Figure 1</strong>  DNA constructs containing β-globulin or tau gene used to transfect neuroblastoma cellsLuciferase gene expression from the constructs was monitored in the absence and presence of a synthetic m7Gpp cap analog (Figure 2).  Translation of Renillla luciferase mRNA depended on ribosomal binding to the m7Gpp cap of the mRNA, but translation of Photinus luciferase required ribosome recruitment by an IRES in the 5′ UTR of the adjacent gene.    <strong>Figure 2</strong>  Luciferase activity in neuroblastoma cells exposed to m7Gpp cap analogIn a second study, researchers used siRNA to target initiation factor eIF4E, a peptide translated in a cap-dependent manner that facilitates the binding of ribosomes to the m7Gpp cap.  Expression of factor eIF4E, elongation factor eEF2K, and tau v2 protein was assessed in siRNA-treated cells (Figure 3).    <strong>Figure 3</strong>  Western blot of eIF4E, eEF2K, and tau v2 extracted from non-AD cells treated with eIF4E siRNA Adapted from Veo BL, Krushel LA. Translation initiation of the human tau mRNA through an internal ribosomal entry site. J Alzheimers Dis. 2009; 16(2):271-5. -Assume gene expression of tau v1 and v2 are synchronized in AD mice cells, and tau mRNA levels are analyzed.  Of the following, which technique would researchers use to identify the tau mRNA isoform with the longer half-life in the cytoplasm of AD mice cells? Figure 2  Luciferase activity in neuroblastoma cells exposed to m7Gpp cap analogIn a second study, researchers used siRNA to target initiation factor eIF4E, a peptide translated in a cap-dependent manner that facilitates the binding of ribosomes to the m7Gpp cap.  Expression of factor eIF4E, elongation factor eEF2K, and tau v2 protein was assessed in siRNA-treated cells (Figure 3). Passage Alzheimer disease (AD) is a progressive condition affecting memory and cognition that can be pathologically characterized by the presence of neurofibrillary tangles (NFTs).  NFTs, aggregates of hyperphosphorylated tau proteins that have dissociated from microtubules, are believed to contribute to neuronal degradation and subsequent AD symptoms.  In general, ribosomes initiate translation of tau mRNA by binding the 7-methylguanosine (m7Gpp) cap present at the end of the 5′ untranslated region (UTR) of the mRNA molecule.  However, researchers believe that tau protein translation initiation can occur without recognition of the m7Gpp cap.  This alternate mechanism, referred to as cap-independent translation, indicates that ribosomes are recruited by internal ribosome entry sites (IRES) generally located in the 5′ UTR of the mRNA sequence.To determine the initiation mechanism of tau mRNA translation, neuroblastoma cells of AD mice were transfected with two different DNA constructs (Figure 1).  Construct 1 contained the 5′ UTR of tau mRNA isoforms (v1 and v2) extracted from cells displaying NFTs.  Construct 2 included the 5′ UTR of the β-globulin gene, which normally codes for a plasma protein.  The luciferase reporter genes, Renillla and Photinus, were also included in the two constructs. /_ /_    <strong>Figure 1</strong>  DNA constructs containing β-globulin or tau gene used to transfect neuroblastoma cellsLuciferase gene expression from the constructs was monitored in the absence and presence of a synthetic m7Gpp cap analog (Figure 2).  Translation of Renillla luciferase mRNA depended on ribosomal binding to the m7Gpp cap of the mRNA, but translation of Photinus luciferase required ribosome recruitment by an IRES in the 5′ UTR of the adjacent gene.    <strong>Figure 2</strong>  Luciferase activity in neuroblastoma cells exposed to m7Gpp cap analogIn a second study, researchers used siRNA to target initiation factor eIF4E, a peptide translated in a cap-dependent manner that facilitates the binding of ribosomes to the m7Gpp cap.  Expression of factor eIF4E, elongation factor eEF2K, and tau v2 protein was assessed in siRNA-treated cells (Figure 3).    <strong>Figure 3</strong>  Western blot of eIF4E, eEF2K, and tau v2 extracted from non-AD cells treated with eIF4E siRNA Adapted from Veo BL, Krushel LA. Translation initiation of the human tau mRNA through an internal ribosomal entry site. J Alzheimers Dis. 2009; 16(2):271-5. -Assume gene expression of tau v1 and v2 are synchronized in AD mice cells, and tau mRNA levels are analyzed.  Of the following, which technique would researchers use to identify the tau mRNA isoform with the longer half-life in the cytoplasm of AD mice cells? Figure 3  Western blot of eIF4E, eEF2K, and tau v2 extracted from non-AD cells treated with eIF4E siRNA Adapted from Veo BL, Krushel LA. Translation initiation of the human tau mRNA through an internal ribosomal entry site. J Alzheimers Dis. 2009; 16(2):271-5. -Assume gene expression of tau v1 and v2 are synchronized in AD mice cells, and tau mRNA levels are analyzed.  Of the following, which technique would researchers use to identify the tau mRNA isoform with the longer half-life in the cytoplasm of AD mice cells?

(Multiple Choice)
4.9/5
(76)

Passage The lac operon encodes the proteins that metabolize lactose and is a key biochemical feature that differentiates between members of the Enterobacteriaceae family.  For example, the severely virulent Salmonella typhimurium can be distinguished from its less virulent relative Escherichia coli by the absence of a lac operon.  Researchers propose that the evolutionary loss of the lac operon may contribute to S. typhimurium's ability to invade epithelial cells.To test the hypothesis, wild-type (WT) S. typhimurium cells were transformed with plasmids encoding components of the lac operon (Figure 1): β-galactosidase (lacZ+), lactose permease (lacY+), transacetylase (lacA+), or all three (lac+).  Each plasmid also contained genes for the lac repressor (lacI), which can inhibit lac operon transcription in the absence of lactose; the cAMP receptor protein (crp), which induces lac expression in low glucose; and a chloramphenicol resistance gene (cat). Passage The lac operon encodes the proteins that metabolize lactose and is a key biochemical feature that differentiates between members of the Enterobacteriaceae family.  For example, the severely virulent Salmonella typhimurium can be distinguished from its less virulent relative Escherichia coli by the absence of a lac operon.  Researchers propose that the evolutionary loss of the lac operon may contribute to S. typhimurium's ability to invade epithelial cells.To test the hypothesis, wild-type (WT) S. typhimurium cells were transformed with plasmids encoding components of the lac operon (Figure 1): β-galactosidase (lacZ<sup>+</sup>), lactose permease (lacY<sup>+</sup>), transacetylase (lacA<sup>+</sup>), or all three (lac<sup>+</sup>).  Each plasmid also contained genes for the lac repressor (lacI), which can inhibit lac operon transcription in the absence of lactose; the cAMP receptor protein (crp), which induces lac expression in low glucose; and a chloramphenicol resistance gene (cat).    <strong>Figure 1</strong>  Plasmid PYM-LACZYA (lac<sup>+</sup>), used to transform WT S. typhimurium.  Similar plasmids containing only one of the three lacZ, lacY, or lacA genes were also used.Virulence assays were performed in mice by inoculating with WT or lac<sup>+</sup> S. typhimurium.  The assays confirmed that lac<sup>+</sup> bacteria were less virulent than their WT counterparts, and that both WT and lac<sup>+</sup> bacteria were more virulent in the presence of glucose.  Subsequently, several genes related to invasion were analyzed for their expression levels in the presence or absence of lac plasmids (Table 1; Figure 2).<strong>Table 1</strong>  Transcription Levels of Invasion-Associated Genes in lac<sup>+</sup> S. typhimurium Relative to WT      <strong>Figure 2</strong>  Transcript concentrations of two S. typhimurium flagellar genes, fljB and fliC, in bacteria transformed with lacZ<sup>+</sup>, lacY<sup>+</sup>, lacA<sup>+</sup>, or lac<sup>+</sup> plasmids.  Concentrations are expressed as a percentage of WT levels. Adapted from Jiang L, Ni Z, Wang L, Feng L, Liu B. Loss of the lac operon contributes to Salmonella invasion of epithelial cells through derepression of flagellar synthesis. Curr Microbiol. 2015;70(3):315-23. -Which table shows the expected survival rates of mice infected with WT or lac<sup>+</sup> S. typhimurium after being fed a glucose-rich (GR) or a lactose-rich (LR) diet for several weeks? Figure 1  Plasmid PYM-LACZYA (lac+), used to transform WT S. typhimurium.  Similar plasmids containing only one of the three lacZ, lacY, or lacA genes were also used.Virulence assays were performed in mice by inoculating with WT or lac+ S. typhimurium.  The assays confirmed that lac+ bacteria were less virulent than their WT counterparts, and that both WT and lac+ bacteria were more virulent in the presence of glucose.  Subsequently, several genes related to invasion were analyzed for their expression levels in the presence or absence of lac plasmids (Table 1; Figure 2).Table 1  Transcription Levels of Invasion-Associated Genes in lac+ S. typhimurium Relative to WT Passage The lac operon encodes the proteins that metabolize lactose and is a key biochemical feature that differentiates between members of the Enterobacteriaceae family.  For example, the severely virulent Salmonella typhimurium can be distinguished from its less virulent relative Escherichia coli by the absence of a lac operon.  Researchers propose that the evolutionary loss of the lac operon may contribute to S. typhimurium's ability to invade epithelial cells.To test the hypothesis, wild-type (WT) S. typhimurium cells were transformed with plasmids encoding components of the lac operon (Figure 1): β-galactosidase (lacZ<sup>+</sup>), lactose permease (lacY<sup>+</sup>), transacetylase (lacA<sup>+</sup>), or all three (lac<sup>+</sup>).  Each plasmid also contained genes for the lac repressor (lacI), which can inhibit lac operon transcription in the absence of lactose; the cAMP receptor protein (crp), which induces lac expression in low glucose; and a chloramphenicol resistance gene (cat).    <strong>Figure 1</strong>  Plasmid PYM-LACZYA (lac<sup>+</sup>), used to transform WT S. typhimurium.  Similar plasmids containing only one of the three lacZ, lacY, or lacA genes were also used.Virulence assays were performed in mice by inoculating with WT or lac<sup>+</sup> S. typhimurium.  The assays confirmed that lac<sup>+</sup> bacteria were less virulent than their WT counterparts, and that both WT and lac<sup>+</sup> bacteria were more virulent in the presence of glucose.  Subsequently, several genes related to invasion were analyzed for their expression levels in the presence or absence of lac plasmids (Table 1; Figure 2).<strong>Table 1</strong>  Transcription Levels of Invasion-Associated Genes in lac<sup>+</sup> S. typhimurium Relative to WT      <strong>Figure 2</strong>  Transcript concentrations of two S. typhimurium flagellar genes, fljB and fliC, in bacteria transformed with lacZ<sup>+</sup>, lacY<sup>+</sup>, lacA<sup>+</sup>, or lac<sup>+</sup> plasmids.  Concentrations are expressed as a percentage of WT levels. Adapted from Jiang L, Ni Z, Wang L, Feng L, Liu B. Loss of the lac operon contributes to Salmonella invasion of epithelial cells through derepression of flagellar synthesis. Curr Microbiol. 2015;70(3):315-23. -Which table shows the expected survival rates of mice infected with WT or lac<sup>+</sup> S. typhimurium after being fed a glucose-rich (GR) or a lactose-rich (LR) diet for several weeks? Passage The lac operon encodes the proteins that metabolize lactose and is a key biochemical feature that differentiates between members of the Enterobacteriaceae family.  For example, the severely virulent Salmonella typhimurium can be distinguished from its less virulent relative Escherichia coli by the absence of a lac operon.  Researchers propose that the evolutionary loss of the lac operon may contribute to S. typhimurium's ability to invade epithelial cells.To test the hypothesis, wild-type (WT) S. typhimurium cells were transformed with plasmids encoding components of the lac operon (Figure 1): β-galactosidase (lacZ<sup>+</sup>), lactose permease (lacY<sup>+</sup>), transacetylase (lacA<sup>+</sup>), or all three (lac<sup>+</sup>).  Each plasmid also contained genes for the lac repressor (lacI), which can inhibit lac operon transcription in the absence of lactose; the cAMP receptor protein (crp), which induces lac expression in low glucose; and a chloramphenicol resistance gene (cat).    <strong>Figure 1</strong>  Plasmid PYM-LACZYA (lac<sup>+</sup>), used to transform WT S. typhimurium.  Similar plasmids containing only one of the three lacZ, lacY, or lacA genes were also used.Virulence assays were performed in mice by inoculating with WT or lac<sup>+</sup> S. typhimurium.  The assays confirmed that lac<sup>+</sup> bacteria were less virulent than their WT counterparts, and that both WT and lac<sup>+</sup> bacteria were more virulent in the presence of glucose.  Subsequently, several genes related to invasion were analyzed for their expression levels in the presence or absence of lac plasmids (Table 1; Figure 2).<strong>Table 1</strong>  Transcription Levels of Invasion-Associated Genes in lac<sup>+</sup> S. typhimurium Relative to WT      <strong>Figure 2</strong>  Transcript concentrations of two S. typhimurium flagellar genes, fljB and fliC, in bacteria transformed with lacZ<sup>+</sup>, lacY<sup>+</sup>, lacA<sup>+</sup>, or lac<sup>+</sup> plasmids.  Concentrations are expressed as a percentage of WT levels. Adapted from Jiang L, Ni Z, Wang L, Feng L, Liu B. Loss of the lac operon contributes to Salmonella invasion of epithelial cells through derepression of flagellar synthesis. Curr Microbiol. 2015;70(3):315-23. -Which table shows the expected survival rates of mice infected with WT or lac<sup>+</sup> S. typhimurium after being fed a glucose-rich (GR) or a lactose-rich (LR) diet for several weeks? Figure 2  Transcript concentrations of two S. typhimurium flagellar genes, fljB and fliC, in bacteria transformed with lacZ+, lacY+, lacA+, or lac+ plasmids.  Concentrations are expressed as a percentage of WT levels. Adapted from Jiang L, Ni Z, Wang L, Feng L, Liu B. Loss of the lac operon contributes to Salmonella invasion of epithelial cells through derepression of flagellar synthesis. Curr Microbiol. 2015;70(3):315-23. -Which table shows the expected survival rates of mice infected with WT or lac+ S. typhimurium after being fed a glucose-rich (GR) or a lactose-rich (LR) diet for several weeks?

(Multiple Choice)
4.9/5
(88)

Passage Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic synovial (joint) inflammation.  RA immunopathogenesis involves LFA-1, a surface receptor found on leukocytes that is composed of an α-chain (CD11a) and a β-chain (CD18).  The binding of LFA-1 to ICAM-1, an adhesion protein on the surface of B cells and endothelial cells, stimulates the migration of leukocytes to specific areas of inflammation.  After successful LFA-1/ICAM-1 binding, CD18 is released into the plasma and synovial fluid (SF), where it exists in soluble form (sCD18).  The levels of sCD18 in SF can be used as a marker for inflammation in RA.CD18 release has been shown to increase in response to tumor necrosis factor (TNF), a pro-inflammatory cytokine involved in the inflammatory response of RA.  In patients with newly diagnosed and untreated RA (eRA), leukocytes produce adequate quantities of LFA-1 and plasma sCD18 levels are unchanged.  However, over time there is dysregulation of LFA-1 synthesis and an increase in competition for ICAM-1 by other ligands, leading to a reduction in CD18 shedding.  As a result, sCD18 is decreased in patients with chronic RA (cRA).Experiment 1An immunofluorescence assay was used to measure plasma sCD18 levels in patients with eRA and cRA, and in age- and gender-matched healthy controls (HC). Passage Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic synovial (joint) inflammation.  RA immunopathogenesis involves LFA-1, a surface receptor found on leukocytes that is composed of an α-chain (CD11a) and a β-chain (CD18).  The binding of LFA-1 to ICAM-1, an adhesion protein on the surface of B cells and endothelial cells, stimulates the migration of leukocytes to specific areas of inflammation.  After successful LFA-1/ICAM-1 binding, CD18 is released into the plasma and synovial fluid (SF), where it exists in soluble form (sCD18).  The levels of sCD18 in SF can be used as a marker for inflammation in RA.CD18 release has been shown to increase in response to tumor necrosis factor (TNF), a pro-inflammatory cytokine involved in the inflammatory response of RA.  In patients with newly diagnosed and untreated RA (eRA), leukocytes produce adequate quantities of LFA-1 and plasma sCD18 levels are unchanged.  However, over time there is dysregulation of LFA-1 synthesis and an increase in competition for ICAM-1 by other ligands, leading to a reduction in CD18 shedding.  As a result, sCD18 is decreased in patients with chronic RA (cRA).Experiment 1An immunofluorescence assay was used to measure plasma sCD18 levels in patients with eRA and cRA, and in age- and gender-matched healthy controls (HC).    <strong>Figure 1</strong>  Baseline sCD18 measurements (Note: 50% of data points are below the median value; median = line inside the box.)Experiment 2Clinical assessments were performed in eRA patients to establish a baseline disease status.  eRA patients were assigned DAS28CRP scores measured by RA-specific laboratory values.  This was followed by treatment with anti-inflammatory drugs.  DAS28CRP scores were calculated at 3-month intervals for 12 months, with lower scores indicating decreased RA severity (Figure 2).    <strong>Figure 2</strong>  DAS28CRP scores in eRA patientsExperiment 3Heterogeneous populations of mononuclear cells were cultured from the synovial fluid (SFMC) and peripheral blood (PBMC) of eRA patients during an acute exacerbation of their symptoms.  sCD18 levels were measured in SFMCs and PBMCs that were untreated, treated with TNF, or treated with monoclonal antibodies targeting TNF (anti-TNF). Adapted from Kragstrup TW, Jalilian B, Keller KK, et al. Changes in Soluble CD18 in Murine Autoimmune Arthritis and Rheumatoid Arthritis Reflect Disease Establishment and Treatment Response. PLoS ONE. 2016;11(2):e0148486. -According to the passage, cells containing the LFA-1 complex on their cell membranes most likely originate in which of the following tissues? Figure 1  Baseline sCD18 measurements (Note: 50% of data points are below the median value; median = line inside the box.)Experiment 2Clinical assessments were performed in eRA patients to establish a baseline disease status.  eRA patients were assigned DAS28CRP scores measured by RA-specific laboratory values.  This was followed by treatment with anti-inflammatory drugs.  DAS28CRP scores were calculated at 3-month intervals for 12 months, with lower scores indicating decreased RA severity (Figure 2). Passage Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic synovial (joint) inflammation.  RA immunopathogenesis involves LFA-1, a surface receptor found on leukocytes that is composed of an α-chain (CD11a) and a β-chain (CD18).  The binding of LFA-1 to ICAM-1, an adhesion protein on the surface of B cells and endothelial cells, stimulates the migration of leukocytes to specific areas of inflammation.  After successful LFA-1/ICAM-1 binding, CD18 is released into the plasma and synovial fluid (SF), where it exists in soluble form (sCD18).  The levels of sCD18 in SF can be used as a marker for inflammation in RA.CD18 release has been shown to increase in response to tumor necrosis factor (TNF), a pro-inflammatory cytokine involved in the inflammatory response of RA.  In patients with newly diagnosed and untreated RA (eRA), leukocytes produce adequate quantities of LFA-1 and plasma sCD18 levels are unchanged.  However, over time there is dysregulation of LFA-1 synthesis and an increase in competition for ICAM-1 by other ligands, leading to a reduction in CD18 shedding.  As a result, sCD18 is decreased in patients with chronic RA (cRA).Experiment 1An immunofluorescence assay was used to measure plasma sCD18 levels in patients with eRA and cRA, and in age- and gender-matched healthy controls (HC).    <strong>Figure 1</strong>  Baseline sCD18 measurements (Note: 50% of data points are below the median value; median = line inside the box.)Experiment 2Clinical assessments were performed in eRA patients to establish a baseline disease status.  eRA patients were assigned DAS28CRP scores measured by RA-specific laboratory values.  This was followed by treatment with anti-inflammatory drugs.  DAS28CRP scores were calculated at 3-month intervals for 12 months, with lower scores indicating decreased RA severity (Figure 2).    <strong>Figure 2</strong>  DAS28CRP scores in eRA patientsExperiment 3Heterogeneous populations of mononuclear cells were cultured from the synovial fluid (SFMC) and peripheral blood (PBMC) of eRA patients during an acute exacerbation of their symptoms.  sCD18 levels were measured in SFMCs and PBMCs that were untreated, treated with TNF, or treated with monoclonal antibodies targeting TNF (anti-TNF). Adapted from Kragstrup TW, Jalilian B, Keller KK, et al. Changes in Soluble CD18 in Murine Autoimmune Arthritis and Rheumatoid Arthritis Reflect Disease Establishment and Treatment Response. PLoS ONE. 2016;11(2):e0148486. -According to the passage, cells containing the LFA-1 complex on their cell membranes most likely originate in which of the following tissues? Figure 2  DAS28CRP scores in eRA patientsExperiment 3Heterogeneous populations of mononuclear cells were cultured from the synovial fluid (SFMC) and peripheral blood (PBMC) of eRA patients during an acute exacerbation of their symptoms.  sCD18 levels were measured in SFMCs and PBMCs that were untreated, treated with TNF, or treated with monoclonal antibodies targeting TNF (anti-TNF). Adapted from Kragstrup TW, Jalilian B, Keller KK, et al. Changes in Soluble CD18 in Murine Autoimmune Arthritis and Rheumatoid Arthritis Reflect Disease Establishment and Treatment Response. PLoS ONE. 2016;11(2):e0148486. -According to the passage, cells containing the LFA-1 complex on their cell membranes most likely originate in which of the following tissues?

(Multiple Choice)
4.8/5
(67)

Passage Beta-thalassemia is a blood disorder caused by reduced production of the β-globin subunit of hemoglobin.  The erythrocytes in patients with beta-thalassemia are abnormally small, lack sufficient functional hemoglobin, and are decreased in number.  These individuals require lifelong blood transfusions to correct their erythrocyte shortage.  Each unit of blood transfused contains many milligrams of iron and, consequently, blood iron levels increase due to repeated transfusions.  The excess iron is then continuously deposited in the organs, leading to organ damage.Transferrin (Tf) is a protein that binds free iron in the blood and plays a key role in erythropoiesis, which requires uptake of iron from the blood in a process facilitated by Tf and its cell surface receptor (TfR).  Iron-bound Tf, known as holotransferrin (holoTf), binds TfR to form a complex that is brought into the developing erythrocyte in an endosome.  Acidification of the endosome triggers a conformational change in holoTf, which allows the release of free iron into the cell and the recycling of the remaining complex components to the cell surface.  Non-iron-bound Tf is referred to as apotransferrin (apoTf), and due to its iron-binding capability, researchers believe that apoTf injections may help prevent deposition of excess iron in the organs of patients with beta-thalassemia.To investigate the effect of apoTf administration in a mouse model of beta-thalassemia, mice homozygous for an inactivating deletion in the murine β-globin gene (Hbbth−3/Hbbth−3) were given blood transfusions followed by apoTf injection.  Measurements of non-transferrin-bound iron in the blood (NTBI), plasma holoTf, and urinary holoTf were taken immediately and at 15 days post-injection.  Results revealed that NTBI decreased over the tested period.  Experimenters hypothesized that apoTf mediated certain regulatory changes that reduced NTBI in Hbbth−3/Hbbth−3 mice by increasing urinary holoTf excretion. -In Hbbth−3/Hbbth−3 mice that received apoTf injections, which of the following tables would best support the conclusion that holoTf excretion is responsible for decreased non-transferrin-bound iron in the blood (NTBI)?

(Multiple Choice)
4.8/5
(90)

Passage Domestic pigs have been used as valuable preclinical models for scientific research due to their numerous anatomical, developmental, and physiological similarities to humans.  For example, oogenesis and embryonic development in pigs are remarkably similar to the human processes and have facilitated the study of impaired fertilization due to decreased oocyte competence (quality).Researchers have hypothesized that early termination of embryo development can arise from low mitochondrial DNA (mtDNA) copy number.  Because mtDNA replication and reduction events have been extensively mapped in pigs, oocytes and sperm were isolated from their respective porcine gonads to test this hypothesis.Experiment 1To evaluate the developmental competence of porcine oocytes, researchers first measured the activity of glucose-6-phosphate dehydrogenase (G6PD), an enzyme that is downregulated as the oocyte matures.  The oocytes were stained with Brilliant Cresyl Blue (BCB), a nontoxic blue dye that is converted to a colorless compound by G6PD.  After 90 minutes of staining, oocytes were divided into two groups: one contained oocytes with colorless cytoplasm (BCB−) and the other contained oocytes with blue cytoplasm (BCB+).  Gene expression profiles were compared to evaluate the number of oocytes in the BCB+ and BCB− groups that had developed to metaphase II.Experiment 2BCB+ and BCB− oocytes underwent in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), or supplementation with homogeneous mitochondria and ICSI (mICSI).  During IVF, an isolated oocyte was placed in a well plate and incubated with sperm at 39 C for 4 hours.  In ICSI, a single sperm was selected and injected directly into the oocyte.Table 1  Developmental Rates for BCB+ and BCB− Oocytes Fertilized Subjected to IVF, ICSI, or mICSI Passage Domestic pigs have been used as valuable preclinical models for scientific research due to their numerous anatomical, developmental, and physiological similarities to humans.  For example, oogenesis and embryonic development in pigs are remarkably similar to the human processes and have facilitated the study of impaired fertilization due to decreased oocyte competence (quality).Researchers have hypothesized that early termination of embryo development can arise from low mitochondrial DNA (mtDNA) copy number.  Because mtDNA replication and reduction events have been extensively mapped in pigs, oocytes and sperm were isolated from their respective porcine gonads to test this hypothesis.Experiment 1To evaluate the developmental competence of porcine oocytes, researchers first measured the activity of glucose-6-phosphate dehydrogenase (G6PD), an enzyme that is downregulated as the oocyte matures.  The oocytes were stained with Brilliant Cresyl Blue (BCB), a nontoxic blue dye that is converted to a colorless compound by G6PD.  After 90 minutes of staining, oocytes were divided into two groups: one contained oocytes with colorless cytoplasm (BCB<sup>−</sup>) and the other contained oocytes with blue cytoplasm (BCB<sup>+</sup>).  Gene expression profiles were compared to evaluate the number of oocytes in the BCB<sup>+</sup> and BCB<sup>−</sup> groups that had developed to metaphase II.Experiment 2BCB<sup>+</sup> and BCB<sup>−</sup> oocytes underwent in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), or supplementation with homogeneous mitochondria and ICSI (mICSI).  During IVF, an isolated oocyte was placed in a well plate and incubated with sperm at 39 C for 4 hours.  In ICSI, a single sperm was selected and injected directly into the oocyte.<strong>Table 1</strong>  Developmental Rates for BCB<sup>+</sup> and BCB<sup>−</sup> Oocytes Fertilized Subjected to IVF, ICSI, or mICSI    Adapted from Cagnone GL, Tsai TS, Makanji Y, et al. Sci Rep. 2016;6:23229. -What conclusions can be made about the production of blastocysts by the fertilization methods shown in Table 1? Adapted from Cagnone GL, Tsai TS, Makanji Y, et al. Sci Rep. 2016;6:23229. -What conclusions can be made about the production of blastocysts by the fertilization methods shown in Table 1?

(Multiple Choice)
4.9/5
(88)

A scientist sequences the genomes of several species and analyzes their evolutionary relationships to a single common ancestor.  The percentage of similarity between the genome of each species to the genome of this ancestor is calculated and shown in the table below. A scientist sequences the genomes of several species and analyzes their evolutionary relationships to a single common ancestor.  The percentage of similarity between the genome of each species to the genome of this ancestor is calculated and shown in the table below.   Which species diverged from the common ancestor first? Which species diverged from the common ancestor first?

(Multiple Choice)
4.9/5
(78)

Passage The adrenal glands are divided into two anatomically distinct regions, the adrenal medulla and the adrenal cortex.  The adrenal medulla is a collection of irregularly shaped cells located in the interior portion of each adrenal gland.  In response to changing serum levels of corticosteroid hormones, medullary cells synthesize and secrete the catecholamines norepinephrine and epinephrine.  Norepinephrine and epinephrine are water-soluble compounds, and their actual secretion into the bloodstream is stimulated by acetylcholine (ACh)-mediated signaling in the sympathetic component of the autonomic nervous system.  Figure 1 shows the enzyme-mediated synthesis of norepinephrine and epinephrine. Passage The adrenal glands are divided into two anatomically distinct regions, the adrenal medulla and the adrenal cortex.  The adrenal medulla is a collection of irregularly shaped cells located in the interior portion of each adrenal gland.  In response to changing serum levels of corticosteroid hormones, medullary cells synthesize and secrete the catecholamines norepinephrine and epinephrine.  Norepinephrine and epinephrine are water-soluble compounds, and their actual secretion into the bloodstream is stimulated by acetylcholine (ACh)-mediated signaling in the sympathetic component of the autonomic nervous system.  Figure 1 shows the enzyme-mediated synthesis of norepinephrine and epinephrine.    <strong>Figure 1</strong>The adrenal cortex is the outer portion of the adrenal gland and is composed of cells that synthesize and secrete lipophilic hormones derived from cholesterol.  Hormones produced by the adrenal cortex include the principal glucocorticoid hormone (cortisol) and the mineralocorticoid hormone (aldosterone).The hypothalamus and pituitary gland regulate and control the endocrine functions of the adrenal cortex (Figure 2).  Secretion of corticotrophin-releasing hormone (CRH) from the hypothalamus promotes the synthesis and release of adrenocorticotrophic hormone (ACTH) by the pituitary gland.  ACTH acts on adrenal cortex cells to promote the growth of cortical tissue and to increase the synthesis and secretion of glucocorticoids.  In addition to its body-wide functions as the principal stress hormone, cortisol also regulates adrenal activity by inhibiting CRH release from the hypothalamus and ACTH release from the pituitary.    <strong>Figure 2</strong> -A woman with low serum cortisol due to partial adrenal dysfunction is treated with high doses of a synthetic cortisol analogue.  According to Figure 2, treatment with a cortisol analogue will most likely cause this patient's serum level of endogenous cortisol to: Figure 1The adrenal cortex is the outer portion of the adrenal gland and is composed of cells that synthesize and secrete lipophilic hormones derived from cholesterol.  Hormones produced by the adrenal cortex include the principal glucocorticoid hormone (cortisol) and the mineralocorticoid hormone (aldosterone).The hypothalamus and pituitary gland regulate and control the endocrine functions of the adrenal cortex (Figure 2).  Secretion of corticotrophin-releasing hormone (CRH) from the hypothalamus promotes the synthesis and release of adrenocorticotrophic hormone (ACTH) by the pituitary gland.  ACTH acts on adrenal cortex cells to promote the growth of cortical tissue and to increase the synthesis and secretion of glucocorticoids.  In addition to its body-wide functions as the principal stress hormone, cortisol also regulates adrenal activity by inhibiting CRH release from the hypothalamus and ACTH release from the pituitary. Passage The adrenal glands are divided into two anatomically distinct regions, the adrenal medulla and the adrenal cortex.  The adrenal medulla is a collection of irregularly shaped cells located in the interior portion of each adrenal gland.  In response to changing serum levels of corticosteroid hormones, medullary cells synthesize and secrete the catecholamines norepinephrine and epinephrine.  Norepinephrine and epinephrine are water-soluble compounds, and their actual secretion into the bloodstream is stimulated by acetylcholine (ACh)-mediated signaling in the sympathetic component of the autonomic nervous system.  Figure 1 shows the enzyme-mediated synthesis of norepinephrine and epinephrine.    <strong>Figure 1</strong>The adrenal cortex is the outer portion of the adrenal gland and is composed of cells that synthesize and secrete lipophilic hormones derived from cholesterol.  Hormones produced by the adrenal cortex include the principal glucocorticoid hormone (cortisol) and the mineralocorticoid hormone (aldosterone).The hypothalamus and pituitary gland regulate and control the endocrine functions of the adrenal cortex (Figure 2).  Secretion of corticotrophin-releasing hormone (CRH) from the hypothalamus promotes the synthesis and release of adrenocorticotrophic hormone (ACTH) by the pituitary gland.  ACTH acts on adrenal cortex cells to promote the growth of cortical tissue and to increase the synthesis and secretion of glucocorticoids.  In addition to its body-wide functions as the principal stress hormone, cortisol also regulates adrenal activity by inhibiting CRH release from the hypothalamus and ACTH release from the pituitary.    <strong>Figure 2</strong> -A woman with low serum cortisol due to partial adrenal dysfunction is treated with high doses of a synthetic cortisol analogue.  According to Figure 2, treatment with a cortisol analogue will most likely cause this patient's serum level of endogenous cortisol to: Figure 2 -A woman with low serum cortisol due to partial adrenal dysfunction is treated with high doses of a synthetic cortisol analogue.  According to Figure 2, treatment with a cortisol analogue will most likely cause this patient's serum level of endogenous cortisol to:

(Multiple Choice)
5.0/5
(82)

Passage Overexpression of the miR-17~92 gene cluster occurs in many human cancers involving c-Myc, a gene coding for a transcription factor that regulates expression of proteins such as p21, an inhibitor of cell cycle progression.  miR-17~92 encodes six distinct microRNAs (miRNAs) that can be divided into four families based on sequence identity at positions 2-7 (Table 1).Table 1  Sequence Identities of miRNA Families Encoded by the mir-17∼92 Gene Cluster Passage Overexpression of the miR-17~92 gene cluster occurs in many human cancers involving c-Myc, a gene coding for a transcription factor that regulates expression of proteins such as p21, an inhibitor of cell cycle progression.  miR-17~92 encodes six distinct microRNAs (miRNAs) that can be divided into four families based on sequence identity at positions 2-7 (Table 1).<strong>Table 1</strong>  Sequence Identities of miRNA Families Encoded by the mir-17∼92 Gene Cluster    Experiment 1Two independent, diffuse B-cell lymphoma cell lines were used to study the functional relationship between miR-17~92 transcripts and c-Myc in cancer pathogenesis.  The first cell line was derived from Eμ-Myc mice (Eμ), which overexpress a c-Myc transgene under the control of a B-cell-specific enhancer that induces early development of B-cell lymphoma.  The second cell line was derived from Eμ-Myc mice carrying a miR-17∼92 knockout allele (Δ/Δ).  As shown in Figure 1, researchers measured the growth of both cell lines, as well as that of Δ/Δ cells infected with a retrovirus expressing the entire miR-17∼92 cluster (Δ/Δ + miR-17∼92).    <strong>Figure 1</strong>  Growth curves of Eμ cells, Δ/Δ cells, and Δ/Δ + miR-17∼92 cells (error bars = standard deviation)Experiment 2To assess the relative contribution of each miRNA to the oncogenic ability of the miR-17∼92 cluster, Δ/Δ cell lines were transduced with an empty vector or with miR-17∼92 mutant allele constructs that were engineered to lack expression of miRNA from at least one of the four families.  In each of the constructs, the family that was knocked out of the vector is indicated by the Δ symbol.  After verifying that the transduced cells correctly expressed the desired miRNA, the fraction of apoptotic cells in each line was measured (Figure 2).    <strong>Figure 2</strong>  Percentage of apoptotic cells in Eμ cells and Δ/Δ cells transduced with the indicated miR-17~92 construct (error bars = standard deviation) Adapted from Mu P, Han YC, Betel D, et al. Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev. 2009;23(24):2806-11. -As described in the passage, verification that the transduced cells expressed the desired miRNA was an essential experimental step to ensure that: Experiment 1Two independent, diffuse B-cell lymphoma cell lines were used to study the functional relationship between miR-17~92 transcripts and c-Myc in cancer pathogenesis.  The first cell line was derived from Eμ-Myc mice (Eμ), which overexpress a c-Myc transgene under the control of a B-cell-specific enhancer that induces early development of B-cell lymphoma.  The second cell line was derived from Eμ-Myc mice carrying a miR-17∼92 knockout allele (Δ/Δ).  As shown in Figure 1, researchers measured the growth of both cell lines, as well as that of Δ/Δ cells infected with a retrovirus expressing the entire miR-17∼92 cluster (Δ/Δ + miR-17∼92). Passage Overexpression of the miR-17~92 gene cluster occurs in many human cancers involving c-Myc, a gene coding for a transcription factor that regulates expression of proteins such as p21, an inhibitor of cell cycle progression.  miR-17~92 encodes six distinct microRNAs (miRNAs) that can be divided into four families based on sequence identity at positions 2-7 (Table 1).<strong>Table 1</strong>  Sequence Identities of miRNA Families Encoded by the mir-17∼92 Gene Cluster    Experiment 1Two independent, diffuse B-cell lymphoma cell lines were used to study the functional relationship between miR-17~92 transcripts and c-Myc in cancer pathogenesis.  The first cell line was derived from Eμ-Myc mice (Eμ), which overexpress a c-Myc transgene under the control of a B-cell-specific enhancer that induces early development of B-cell lymphoma.  The second cell line was derived from Eμ-Myc mice carrying a miR-17∼92 knockout allele (Δ/Δ).  As shown in Figure 1, researchers measured the growth of both cell lines, as well as that of Δ/Δ cells infected with a retrovirus expressing the entire miR-17∼92 cluster (Δ/Δ + miR-17∼92).    <strong>Figure 1</strong>  Growth curves of Eμ cells, Δ/Δ cells, and Δ/Δ + miR-17∼92 cells (error bars = standard deviation)Experiment 2To assess the relative contribution of each miRNA to the oncogenic ability of the miR-17∼92 cluster, Δ/Δ cell lines were transduced with an empty vector or with miR-17∼92 mutant allele constructs that were engineered to lack expression of miRNA from at least one of the four families.  In each of the constructs, the family that was knocked out of the vector is indicated by the Δ symbol.  After verifying that the transduced cells correctly expressed the desired miRNA, the fraction of apoptotic cells in each line was measured (Figure 2).    <strong>Figure 2</strong>  Percentage of apoptotic cells in Eμ cells and Δ/Δ cells transduced with the indicated miR-17~92 construct (error bars = standard deviation) Adapted from Mu P, Han YC, Betel D, et al. Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev. 2009;23(24):2806-11. -As described in the passage, verification that the transduced cells expressed the desired miRNA was an essential experimental step to ensure that: Figure 1  Growth curves of Eμ cells, Δ/Δ cells, and Δ/Δ + miR-17∼92 cells (error bars = standard deviation)Experiment 2To assess the relative contribution of each miRNA to the oncogenic ability of the miR-17∼92 cluster, Δ/Δ cell lines were transduced with an empty vector or with miR-17∼92 mutant allele constructs that were engineered to lack expression of miRNA from at least one of the four families.  In each of the constructs, the family that was knocked out of the vector is indicated by the Δ symbol.  After verifying that the transduced cells correctly expressed the desired miRNA, the fraction of apoptotic cells in each line was measured (Figure 2). Passage Overexpression of the miR-17~92 gene cluster occurs in many human cancers involving c-Myc, a gene coding for a transcription factor that regulates expression of proteins such as p21, an inhibitor of cell cycle progression.  miR-17~92 encodes six distinct microRNAs (miRNAs) that can be divided into four families based on sequence identity at positions 2-7 (Table 1).<strong>Table 1</strong>  Sequence Identities of miRNA Families Encoded by the mir-17∼92 Gene Cluster    Experiment 1Two independent, diffuse B-cell lymphoma cell lines were used to study the functional relationship between miR-17~92 transcripts and c-Myc in cancer pathogenesis.  The first cell line was derived from Eμ-Myc mice (Eμ), which overexpress a c-Myc transgene under the control of a B-cell-specific enhancer that induces early development of B-cell lymphoma.  The second cell line was derived from Eμ-Myc mice carrying a miR-17∼92 knockout allele (Δ/Δ).  As shown in Figure 1, researchers measured the growth of both cell lines, as well as that of Δ/Δ cells infected with a retrovirus expressing the entire miR-17∼92 cluster (Δ/Δ + miR-17∼92).    <strong>Figure 1</strong>  Growth curves of Eμ cells, Δ/Δ cells, and Δ/Δ + miR-17∼92 cells (error bars = standard deviation)Experiment 2To assess the relative contribution of each miRNA to the oncogenic ability of the miR-17∼92 cluster, Δ/Δ cell lines were transduced with an empty vector or with miR-17∼92 mutant allele constructs that were engineered to lack expression of miRNA from at least one of the four families.  In each of the constructs, the family that was knocked out of the vector is indicated by the Δ symbol.  After verifying that the transduced cells correctly expressed the desired miRNA, the fraction of apoptotic cells in each line was measured (Figure 2).    <strong>Figure 2</strong>  Percentage of apoptotic cells in Eμ cells and Δ/Δ cells transduced with the indicated miR-17~92 construct (error bars = standard deviation) Adapted from Mu P, Han YC, Betel D, et al. Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev. 2009;23(24):2806-11. -As described in the passage, verification that the transduced cells expressed the desired miRNA was an essential experimental step to ensure that: Figure 2  Percentage of apoptotic cells in Eμ cells and Δ/Δ cells transduced with the indicated miR-17~92 construct (error bars = standard deviation) Adapted from Mu P, Han YC, Betel D, et al. Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev. 2009;23(24):2806-11. -As described in the passage, verification that the transduced cells expressed the desired miRNA was an essential experimental step to ensure that:

(Multiple Choice)
4.9/5
(88)

Scientists identified two distinct pathogens in blood samples taken from mice.  They analyzed both pathogens in the laboratory and recorded the presence or absence of certain characteristics in the table below (NOTE: + indicates presence and − indicates absence). Scientists identified two distinct pathogens in blood samples taken from mice.  They analyzed both pathogens in the laboratory and recorded the presence or absence of certain characteristics in the table below (NOTE: + indicates presence and − indicates absence).   They concluded that both pathogens are prokaryotic cells.  Do the data support this conclusion? They concluded that both pathogens are prokaryotic cells.  Do the data support this conclusion?

(Multiple Choice)
4.9/5
(80)

Passage Lipopolysaccharides (LPS) found in gram-negative bacterial cells can elicit a lethal degree of adjuvanticity, or immune activation, in LPS-responsive host organisms.  In mice, responses may be modulated by abnormalities in the toll-like receptor (TLR) encoded by the Tlr4 gene closely linked to coat color on Chromosome 4.  To investigate the effect of a particular Tlr4 mutation on LPS response, three experiments were performed following a cross between fully responsive He-N mice [tlr4(+)/tlr4(+)] and He-J mice homozygous for the mutation [tlr4(d)/tlr4(d)].Experiment 1Researchers isolated spleen cells for analysis of protein expression and LPS response.  In cells isolated from F1 mice, both wild-type and mutant TLRs were distinguishable by protein electrophoresis.  Following this first analysis, spleen cells from each cohort were exposed to 2 × 105 SRC, an antigen formed by sheep erythrocytes.  Cultures were then incubated in the presence or absence of Ph-LPS, with LPS extracted from Escherichia coli K345 cells using a phenol-water mixture.  Titers of anti-SRC antibody were recorded on incubation day 5, with the results shown in Table 1.Table 1  Mean anti-SRC titers with standard error Passage Lipopolysaccharides (LPS) found in gram-negative bacterial cells can elicit a lethal degree of adjuvanticity, or immune activation, in LPS-responsive host organisms.  In mice, responses may be modulated by abnormalities in the toll-like receptor (TLR) encoded by the Tlr4 gene closely linked to coat color on Chromosome 4.  To investigate the effect of a particular Tlr4 mutation on LPS response, three experiments were performed following a cross between fully responsive He-N mice [tlr4(+)/tlr4(+)] and He-J mice homozygous for the mutation [tlr4(d)/tlr4(d)].Experiment 1Researchers isolated spleen cells for analysis of protein expression and LPS response.  In cells isolated from F1 mice, both wild-type and mutant TLRs were distinguishable by protein electrophoresis.  Following this first analysis, spleen cells from each cohort were exposed to 2 × 10<sup>5</sup> SRC, an antigen formed by sheep erythrocytes.  Cultures were then incubated in the presence or absence of Ph-LPS, with LPS extracted from Escherichia coli K345 cells using a phenol-water mixture.  Titers of anti-SRC antibody were recorded on incubation day 5, with the results shown in Table 1.<strong>Table 1</strong>  Mean anti-SRC titers with standard error    Experiment 2Serum samples were assayed for interferon production 2 hours post LPS injection.  Interferon was quantified using a plaque reduction assay on mouse cells challenged with vesicular stomatitis virus.    <strong>Figure 1</strong>  Average serum interferon levels in mice cohortsExperiment 3Mice were injected with varying doses of Ph-LPS and monitored for 4 days.  The lethal dose (LD<sub>50</sub>) was defined as the minimum dose causing death in 50% of injected mice.  Compared to He-N mice, results reflected a 10-fold increase in LD<sub>50</sub> for F1 mice and a 100-fold increase in LD<sub>50</sub> for He-J mice. -According to the results of Experiment 3, which of the following could represent survival curves for F1 and He-J mice? Experiment 2Serum samples were assayed for interferon production 2 hours post LPS injection.  Interferon was quantified using a plaque reduction assay on mouse cells challenged with vesicular stomatitis virus. Passage Lipopolysaccharides (LPS) found in gram-negative bacterial cells can elicit a lethal degree of adjuvanticity, or immune activation, in LPS-responsive host organisms.  In mice, responses may be modulated by abnormalities in the toll-like receptor (TLR) encoded by the Tlr4 gene closely linked to coat color on Chromosome 4.  To investigate the effect of a particular Tlr4 mutation on LPS response, three experiments were performed following a cross between fully responsive He-N mice [tlr4(+)/tlr4(+)] and He-J mice homozygous for the mutation [tlr4(d)/tlr4(d)].Experiment 1Researchers isolated spleen cells for analysis of protein expression and LPS response.  In cells isolated from F1 mice, both wild-type and mutant TLRs were distinguishable by protein electrophoresis.  Following this first analysis, spleen cells from each cohort were exposed to 2 × 10<sup>5</sup> SRC, an antigen formed by sheep erythrocytes.  Cultures were then incubated in the presence or absence of Ph-LPS, with LPS extracted from Escherichia coli K345 cells using a phenol-water mixture.  Titers of anti-SRC antibody were recorded on incubation day 5, with the results shown in Table 1.<strong>Table 1</strong>  Mean anti-SRC titers with standard error    Experiment 2Serum samples were assayed for interferon production 2 hours post LPS injection.  Interferon was quantified using a plaque reduction assay on mouse cells challenged with vesicular stomatitis virus.    <strong>Figure 1</strong>  Average serum interferon levels in mice cohortsExperiment 3Mice were injected with varying doses of Ph-LPS and monitored for 4 days.  The lethal dose (LD<sub>50</sub>) was defined as the minimum dose causing death in 50% of injected mice.  Compared to He-N mice, results reflected a 10-fold increase in LD<sub>50</sub> for F1 mice and a 100-fold increase in LD<sub>50</sub> for He-J mice. -According to the results of Experiment 3, which of the following could represent survival curves for F1 and He-J mice? Figure 1  Average serum interferon levels in mice cohortsExperiment 3Mice were injected with varying doses of Ph-LPS and monitored for 4 days.  The lethal dose (LD50) was defined as the minimum dose causing death in 50% of injected mice.  Compared to He-N mice, results reflected a 10-fold increase in LD50 for F1 mice and a 100-fold increase in LD50 for He-J mice. -According to the results of Experiment 3, which of the following could represent survival curves for F1 and He-J mice?

(Multiple Choice)
4.7/5
(85)

Passage Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease affecting 1 in 10,000 live births.  The pathological hallmark of SMA is the loss of α-motor neurons in the spinal cord, which causes progressive paralysis and, ultimately, premature death in infants.  SMA is caused by insufficient levels of survival motor neuron (SMN), a regulatory protein required for the maintenance of the spinal cord nerve cells that control voluntary muscle movement.The SMN protein is generated from the SMN1 and SMN2 genes, which differ in sequence by only a single nucleotide in exon 7.  In healthy individuals, the gene product of SMN1 is the full-length (FL) SMN protein, and the gene products of SMN2 are both the FL-SMN protein as well as a truncated unstable protein (SMNΔ7) that is rapidly degraded.  Approximately 90% of the SMN2 gene product is SMNΔ7, and only 10% is FL-SMN (Figure 1).  In most patients with SMA, SMN1 is mutated such that its protein product is nonfunctional or deleted.  The disease phenotype arises because the SMN2 gene cannot fully compensate for the deficiency in FL-SMN protein synthesis. Passage Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease affecting 1 in 10,000 live births.  The pathological hallmark of SMA is the loss of α-motor neurons in the spinal cord, which causes progressive paralysis and, ultimately, premature death in infants.  SMA is caused by insufficient levels of survival motor neuron (SMN), a regulatory protein required for the maintenance of the spinal cord nerve cells that control voluntary muscle movement.The SMN protein is generated from the SMN1 and SMN2 genes, which differ in sequence by only a single nucleotide in exon 7.  In healthy individuals, the gene product of SMN1 is the full-length (FL) SMN protein, and the gene products of SMN2 are both the FL-SMN protein as well as a truncated unstable protein (SMNΔ7) that is rapidly degraded.  Approximately 90% of the SMN2 gene product is SMNΔ7, and only 10% is FL-SMN (Figure 1).  In most patients with SMA, SMN1 is mutated such that its protein product is nonfunctional or deleted.  The disease phenotype arises because the SMN2 gene cannot fully compensate for the deficiency in FL-SMN protein synthesis.    <strong>Figure 1</strong>  Structure of SMN1 and SMN2 transcriptsAntisense oligonucleotides (ASOs) that bind pre-mRNA were injected into SMA mice (SMN1<sup>−/−</sup>, SMN2<sup>+/+</sup>) exhibiting progressive tail necrosis, a characteristic measure of SMA severity.  ASO therapy effectiveness was assessed by measuring the tail length of wild-type (WT) mice and SMA mice exposed to increasing concentrations of ASOs (Figure 2).    <strong>Figure 2</strong>  Tail length progression of WT mice compared to SMA mice treated with either saline or ASOs Adapted from Lorson CL, Hahnen E, Androphy EJ, Wirth B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA. 1999;96(11):6307-11. -Which of the following splicing mechanisms contributes to SMA pathology?  (Note:  SD = splice donor site; SA = splice acceptor site.) Figure 1  Structure of SMN1 and SMN2 transcriptsAntisense oligonucleotides (ASOs) that bind pre-mRNA were injected into SMA mice (SMN1−/−, SMN2+/+) exhibiting progressive tail necrosis, a characteristic measure of SMA severity.  ASO therapy effectiveness was assessed by measuring the tail length of wild-type (WT) mice and SMA mice exposed to increasing concentrations of ASOs (Figure 2). Passage Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease affecting 1 in 10,000 live births.  The pathological hallmark of SMA is the loss of α-motor neurons in the spinal cord, which causes progressive paralysis and, ultimately, premature death in infants.  SMA is caused by insufficient levels of survival motor neuron (SMN), a regulatory protein required for the maintenance of the spinal cord nerve cells that control voluntary muscle movement.The SMN protein is generated from the SMN1 and SMN2 genes, which differ in sequence by only a single nucleotide in exon 7.  In healthy individuals, the gene product of SMN1 is the full-length (FL) SMN protein, and the gene products of SMN2 are both the FL-SMN protein as well as a truncated unstable protein (SMNΔ7) that is rapidly degraded.  Approximately 90% of the SMN2 gene product is SMNΔ7, and only 10% is FL-SMN (Figure 1).  In most patients with SMA, SMN1 is mutated such that its protein product is nonfunctional or deleted.  The disease phenotype arises because the SMN2 gene cannot fully compensate for the deficiency in FL-SMN protein synthesis.    <strong>Figure 1</strong>  Structure of SMN1 and SMN2 transcriptsAntisense oligonucleotides (ASOs) that bind pre-mRNA were injected into SMA mice (SMN1<sup>−/−</sup>, SMN2<sup>+/+</sup>) exhibiting progressive tail necrosis, a characteristic measure of SMA severity.  ASO therapy effectiveness was assessed by measuring the tail length of wild-type (WT) mice and SMA mice exposed to increasing concentrations of ASOs (Figure 2).    <strong>Figure 2</strong>  Tail length progression of WT mice compared to SMA mice treated with either saline or ASOs Adapted from Lorson CL, Hahnen E, Androphy EJ, Wirth B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA. 1999;96(11):6307-11. -Which of the following splicing mechanisms contributes to SMA pathology?  (Note:  SD = splice donor site; SA = splice acceptor site.) Figure 2  Tail length progression of WT mice compared to SMA mice treated with either saline or ASOs Adapted from Lorson CL, Hahnen E, Androphy EJ, Wirth B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA. 1999;96(11):6307-11. -Which of the following splicing mechanisms contributes to SMA pathology?  (Note:  SD = splice donor site; SA = splice acceptor site.)

(Multiple Choice)
4.9/5
(69)

Passage Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease affecting 1 in 10,000 live births.  The pathological hallmark of SMA is the loss of α-motor neurons in the spinal cord, which causes progressive paralysis and, ultimately, premature death in infants.  SMA is caused by insufficient levels of survival motor neuron (SMN), a regulatory protein required for the maintenance of the spinal cord nerve cells that control voluntary muscle movement.The SMN protein is generated from the SMN1 and SMN2 genes, which differ in sequence by only a single nucleotide in exon 7.  In healthy individuals, the gene product of SMN1 is the full-length (FL) SMN protein, and the gene products of SMN2 are both the FL-SMN protein as well as a truncated unstable protein (SMNΔ7) that is rapidly degraded.  Approximately 90% of the SMN2 gene product is SMNΔ7, and only 10% is FL-SMN (Figure 1).  In most patients with SMA, SMN1 is mutated such that its protein product is nonfunctional or deleted.  The disease phenotype arises because the SMN2 gene cannot fully compensate for the deficiency in FL-SMN protein synthesis. Passage Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease affecting 1 in 10,000 live births.  The pathological hallmark of SMA is the loss of α-motor neurons in the spinal cord, which causes progressive paralysis and, ultimately, premature death in infants.  SMA is caused by insufficient levels of survival motor neuron (SMN), a regulatory protein required for the maintenance of the spinal cord nerve cells that control voluntary muscle movement.The SMN protein is generated from the SMN1 and SMN2 genes, which differ in sequence by only a single nucleotide in exon 7.  In healthy individuals, the gene product of SMN1 is the full-length (FL) SMN protein, and the gene products of SMN2 are both the FL-SMN protein as well as a truncated unstable protein (SMNΔ7) that is rapidly degraded.  Approximately 90% of the SMN2 gene product is SMNΔ7, and only 10% is FL-SMN (Figure 1).  In most patients with SMA, SMN1 is mutated such that its protein product is nonfunctional or deleted.  The disease phenotype arises because the SMN2 gene cannot fully compensate for the deficiency in FL-SMN protein synthesis.    <strong>Figure 1</strong>  Structure of SMN1 and SMN2 transcriptsAntisense oligonucleotides (ASOs) that bind pre-mRNA were injected into SMA mice (SMN1<sup>−/−</sup>, SMN2<sup>+/+</sup>) exhibiting progressive tail necrosis, a characteristic measure of SMA severity.  ASO therapy effectiveness was assessed by measuring the tail length of wild-type (WT) mice and SMA mice exposed to increasing concentrations of ASOs (Figure 2).    <strong>Figure 2</strong>  Tail length progression of WT mice compared to SMA mice treated with either saline or ASOs Adapted from Lorson CL, Hahnen E, Androphy EJ, Wirth B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA. 1999;96(11):6307-11. -Researchers have discovered that SMN plays a role in its own mRNA processing, and that FL-SMN enhances the expression of small nuclear RNAs (snRNA) required to produce mature FL-SMN mRNA.  In motor neurons of SMA patients, the feedback mechanism between SMN protein and SMN mature mRNA is shown in which northern blot sample? Figure 1  Structure of SMN1 and SMN2 transcriptsAntisense oligonucleotides (ASOs) that bind pre-mRNA were injected into SMA mice (SMN1−/−, SMN2+/+) exhibiting progressive tail necrosis, a characteristic measure of SMA severity.  ASO therapy effectiveness was assessed by measuring the tail length of wild-type (WT) mice and SMA mice exposed to increasing concentrations of ASOs (Figure 2). Passage Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease affecting 1 in 10,000 live births.  The pathological hallmark of SMA is the loss of α-motor neurons in the spinal cord, which causes progressive paralysis and, ultimately, premature death in infants.  SMA is caused by insufficient levels of survival motor neuron (SMN), a regulatory protein required for the maintenance of the spinal cord nerve cells that control voluntary muscle movement.The SMN protein is generated from the SMN1 and SMN2 genes, which differ in sequence by only a single nucleotide in exon 7.  In healthy individuals, the gene product of SMN1 is the full-length (FL) SMN protein, and the gene products of SMN2 are both the FL-SMN protein as well as a truncated unstable protein (SMNΔ7) that is rapidly degraded.  Approximately 90% of the SMN2 gene product is SMNΔ7, and only 10% is FL-SMN (Figure 1).  In most patients with SMA, SMN1 is mutated such that its protein product is nonfunctional or deleted.  The disease phenotype arises because the SMN2 gene cannot fully compensate for the deficiency in FL-SMN protein synthesis.    <strong>Figure 1</strong>  Structure of SMN1 and SMN2 transcriptsAntisense oligonucleotides (ASOs) that bind pre-mRNA were injected into SMA mice (SMN1<sup>−/−</sup>, SMN2<sup>+/+</sup>) exhibiting progressive tail necrosis, a characteristic measure of SMA severity.  ASO therapy effectiveness was assessed by measuring the tail length of wild-type (WT) mice and SMA mice exposed to increasing concentrations of ASOs (Figure 2).    <strong>Figure 2</strong>  Tail length progression of WT mice compared to SMA mice treated with either saline or ASOs Adapted from Lorson CL, Hahnen E, Androphy EJ, Wirth B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA. 1999;96(11):6307-11. -Researchers have discovered that SMN plays a role in its own mRNA processing, and that FL-SMN enhances the expression of small nuclear RNAs (snRNA) required to produce mature FL-SMN mRNA.  In motor neurons of SMA patients, the feedback mechanism between SMN protein and SMN mature mRNA is shown in which northern blot sample? Figure 2  Tail length progression of WT mice compared to SMA mice treated with either saline or ASOs Adapted from Lorson CL, Hahnen E, Androphy EJ, Wirth B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA. 1999;96(11):6307-11. -Researchers have discovered that SMN plays a role in its own mRNA processing, and that FL-SMN enhances the expression of small nuclear RNAs (snRNA) required to produce mature FL-SMN mRNA.  In motor neurons of SMA patients, the feedback mechanism between SMN protein and SMN mature mRNA is shown in which northern blot sample?

(Multiple Choice)
4.8/5
(85)

Passage Alzheimer disease (AD) is a progressive condition affecting memory and cognition that can be pathologically characterized by the presence of neurofibrillary tangles (NFTs).  NFTs, aggregates of hyperphosphorylated tau proteins that have dissociated from microtubules, are believed to contribute to neuronal degradation and subsequent AD symptoms.  In general, ribosomes initiate translation of tau mRNA by binding the 7-methylguanosine (m7Gpp) cap present at the end of the 5′ untranslated region (UTR) of the mRNA molecule.  However, researchers believe that tau protein translation initiation can occur without recognition of the m7Gpp cap.  This alternate mechanism, referred to as cap-independent translation, indicates that ribosomes are recruited by internal ribosome entry sites (IRES) generally located in the 5′ UTR of the mRNA sequence.To determine the initiation mechanism of tau mRNA translation, neuroblastoma cells of AD mice were transfected with two different DNA constructs (Figure 1).  Construct 1 contained the 5′ UTR of tau mRNA isoforms (v1 and v2) extracted from cells displaying NFTs.  Construct 2 included the 5′ UTR of the β-globulin gene, which normally codes for a plasma protein.  The luciferase reporter genes, Renillla and Photinus, were also included in the two constructs. /_ /_ Passage Alzheimer disease (AD) is a progressive condition affecting memory and cognition that can be pathologically characterized by the presence of neurofibrillary tangles (NFTs).  NFTs, aggregates of hyperphosphorylated tau proteins that have dissociated from microtubules, are believed to contribute to neuronal degradation and subsequent AD symptoms.  In general, ribosomes initiate translation of tau mRNA by binding the 7-methylguanosine (m7Gpp) cap present at the end of the 5′ untranslated region (UTR) of the mRNA molecule.  However, researchers believe that tau protein translation initiation can occur without recognition of the m7Gpp cap.  This alternate mechanism, referred to as cap-independent translation, indicates that ribosomes are recruited by internal ribosome entry sites (IRES) generally located in the 5′ UTR of the mRNA sequence.To determine the initiation mechanism of tau mRNA translation, neuroblastoma cells of AD mice were transfected with two different DNA constructs (Figure 1).  Construct 1 contained the 5′ UTR of tau mRNA isoforms (v1 and v2) extracted from cells displaying NFTs.  Construct 2 included the 5′ UTR of the β-globulin gene, which normally codes for a plasma protein.  The luciferase reporter genes, Renillla and Photinus, were also included in the two constructs. /_ /_    <strong>Figure 1</strong>  DNA constructs containing β-globulin or tau gene used to transfect neuroblastoma cellsLuciferase gene expression from the constructs was monitored in the absence and presence of a synthetic m7Gpp cap analog (Figure 2).  Translation of Renillla luciferase mRNA depended on ribosomal binding to the m7Gpp cap of the mRNA, but translation of Photinus luciferase required ribosome recruitment by an IRES in the 5′ UTR of the adjacent gene.    <strong>Figure 2</strong>  Luciferase activity in neuroblastoma cells exposed to m7Gpp cap analogIn a second study, researchers used siRNA to target initiation factor eIF4E, a peptide translated in a cap-dependent manner that facilitates the binding of ribosomes to the m7Gpp cap.  Expression of factor eIF4E, elongation factor eEF2K, and tau v2 protein was assessed in siRNA-treated cells (Figure 3).    <strong>Figure 3</strong>  Western blot of eIF4E, eEF2K, and tau v2 extracted from non-AD cells treated with eIF4E siRNA Adapted from Veo BL, Krushel LA. Translation initiation of the human tau mRNA through an internal ribosomal entry site. J Alzheimers Dis. 2009; 16(2):271-5. -The researchers hypothesize that miR-26a overexpression can rescue obesity-induced insulin resistance.  Which experimental result would NOT support their hypothesis? Figure 1  DNA constructs containing β-globulin or tau gene used to transfect neuroblastoma cellsLuciferase gene expression from the constructs was monitored in the absence and presence of a synthetic m7Gpp cap analog (Figure 2).  Translation of Renillla luciferase mRNA depended on ribosomal binding to the m7Gpp cap of the mRNA, but translation of Photinus luciferase required ribosome recruitment by an IRES in the 5′ UTR of the adjacent gene. Passage Alzheimer disease (AD) is a progressive condition affecting memory and cognition that can be pathologically characterized by the presence of neurofibrillary tangles (NFTs).  NFTs, aggregates of hyperphosphorylated tau proteins that have dissociated from microtubules, are believed to contribute to neuronal degradation and subsequent AD symptoms.  In general, ribosomes initiate translation of tau mRNA by binding the 7-methylguanosine (m7Gpp) cap present at the end of the 5′ untranslated region (UTR) of the mRNA molecule.  However, researchers believe that tau protein translation initiation can occur without recognition of the m7Gpp cap.  This alternate mechanism, referred to as cap-independent translation, indicates that ribosomes are recruited by internal ribosome entry sites (IRES) generally located in the 5′ UTR of the mRNA sequence.To determine the initiation mechanism of tau mRNA translation, neuroblastoma cells of AD mice were transfected with two different DNA constructs (Figure 1).  Construct 1 contained the 5′ UTR of tau mRNA isoforms (v1 and v2) extracted from cells displaying NFTs.  Construct 2 included the 5′ UTR of the β-globulin gene, which normally codes for a plasma protein.  The luciferase reporter genes, Renillla and Photinus, were also included in the two constructs. /_ /_    <strong>Figure 1</strong>  DNA constructs containing β-globulin or tau gene used to transfect neuroblastoma cellsLuciferase gene expression from the constructs was monitored in the absence and presence of a synthetic m7Gpp cap analog (Figure 2).  Translation of Renillla luciferase mRNA depended on ribosomal binding to the m7Gpp cap of the mRNA, but translation of Photinus luciferase required ribosome recruitment by an IRES in the 5′ UTR of the adjacent gene.    <strong>Figure 2</strong>  Luciferase activity in neuroblastoma cells exposed to m7Gpp cap analogIn a second study, researchers used siRNA to target initiation factor eIF4E, a peptide translated in a cap-dependent manner that facilitates the binding of ribosomes to the m7Gpp cap.  Expression of factor eIF4E, elongation factor eEF2K, and tau v2 protein was assessed in siRNA-treated cells (Figure 3).    <strong>Figure 3</strong>  Western blot of eIF4E, eEF2K, and tau v2 extracted from non-AD cells treated with eIF4E siRNA Adapted from Veo BL, Krushel LA. Translation initiation of the human tau mRNA through an internal ribosomal entry site. J Alzheimers Dis. 2009; 16(2):271-5. -The researchers hypothesize that miR-26a overexpression can rescue obesity-induced insulin resistance.  Which experimental result would NOT support their hypothesis? Figure 2  Luciferase activity in neuroblastoma cells exposed to m7Gpp cap analogIn a second study, researchers used siRNA to target initiation factor eIF4E, a peptide translated in a cap-dependent manner that facilitates the binding of ribosomes to the m7Gpp cap.  Expression of factor eIF4E, elongation factor eEF2K, and tau v2 protein was assessed in siRNA-treated cells (Figure 3). Passage Alzheimer disease (AD) is a progressive condition affecting memory and cognition that can be pathologically characterized by the presence of neurofibrillary tangles (NFTs).  NFTs, aggregates of hyperphosphorylated tau proteins that have dissociated from microtubules, are believed to contribute to neuronal degradation and subsequent AD symptoms.  In general, ribosomes initiate translation of tau mRNA by binding the 7-methylguanosine (m7Gpp) cap present at the end of the 5′ untranslated region (UTR) of the mRNA molecule.  However, researchers believe that tau protein translation initiation can occur without recognition of the m7Gpp cap.  This alternate mechanism, referred to as cap-independent translation, indicates that ribosomes are recruited by internal ribosome entry sites (IRES) generally located in the 5′ UTR of the mRNA sequence.To determine the initiation mechanism of tau mRNA translation, neuroblastoma cells of AD mice were transfected with two different DNA constructs (Figure 1).  Construct 1 contained the 5′ UTR of tau mRNA isoforms (v1 and v2) extracted from cells displaying NFTs.  Construct 2 included the 5′ UTR of the β-globulin gene, which normally codes for a plasma protein.  The luciferase reporter genes, Renillla and Photinus, were also included in the two constructs. /_ /_    <strong>Figure 1</strong>  DNA constructs containing β-globulin or tau gene used to transfect neuroblastoma cellsLuciferase gene expression from the constructs was monitored in the absence and presence of a synthetic m7Gpp cap analog (Figure 2).  Translation of Renillla luciferase mRNA depended on ribosomal binding to the m7Gpp cap of the mRNA, but translation of Photinus luciferase required ribosome recruitment by an IRES in the 5′ UTR of the adjacent gene.    <strong>Figure 2</strong>  Luciferase activity in neuroblastoma cells exposed to m7Gpp cap analogIn a second study, researchers used siRNA to target initiation factor eIF4E, a peptide translated in a cap-dependent manner that facilitates the binding of ribosomes to the m7Gpp cap.  Expression of factor eIF4E, elongation factor eEF2K, and tau v2 protein was assessed in siRNA-treated cells (Figure 3).    <strong>Figure 3</strong>  Western blot of eIF4E, eEF2K, and tau v2 extracted from non-AD cells treated with eIF4E siRNA Adapted from Veo BL, Krushel LA. Translation initiation of the human tau mRNA through an internal ribosomal entry site. J Alzheimers Dis. 2009; 16(2):271-5. -The researchers hypothesize that miR-26a overexpression can rescue obesity-induced insulin resistance.  Which experimental result would NOT support their hypothesis? Figure 3  Western blot of eIF4E, eEF2K, and tau v2 extracted from non-AD cells treated with eIF4E siRNA Adapted from Veo BL, Krushel LA. Translation initiation of the human tau mRNA through an internal ribosomal entry site. J Alzheimers Dis. 2009; 16(2):271-5. -The researchers hypothesize that miR-26a overexpression can rescue obesity-induced insulin resistance.  Which experimental result would NOT support their hypothesis?

(Multiple Choice)
4.9/5
(85)

Passage The nicotinic acetylcholine receptor (nAChR) is a protein embedded in the muscle fiber membrane that facilitates cell-to-cell communication across the neuromuscular junction.  When acetylcholine (ACh) binds nAChR, electrical depolarization within skeletal muscle fibers is induced and ultimately gives rise to contractile activity.  The nAChR is composed of five protein subunits symmetrically organized around a central ion pore.  Previous studies demonstrated that these subunits may serve as epitopes (antibody binding sites) in autoimmune disease.  By reversibly binding nAChR subunits, anti-nAChr antibodies may temporarily block the attachment site for ACh, resulting in muscle weakness.Researchers harvested muscle samples from mice to investigate the effects of anti-nAChR antibodies on muscle tension, the pulling force transmitted by muscles during contraction.Experiment 1First, skeletal muscle samples (tibialis anterior) of adult male mice were surgically harvested (n = 30), washed, and stripped of connective tissues.  Next, the isolated muscle samples were placed in a 150-mL oxygen-infused, electrolyte-rich bath containing glucose and Ca2+ ions that were able to enter the muscle fibers and enable maximal contractile force.  One end of the submerged muscle was anchored in place while the other was attached to an apparatus that measures muscle tension and modifies muscle length.  Using electrodes, action potentials were elicited in the harvested muscle tissue to evaluate contractile function (Figure 1). Passage The nicotinic acetylcholine receptor (nAChR) is a protein embedded in the muscle fiber membrane that facilitates cell-to-cell communication across the neuromuscular junction.  When acetylcholine (ACh) binds nAChR, electrical depolarization within skeletal muscle fibers is induced and ultimately gives rise to contractile activity.  The nAChR is composed of five protein subunits symmetrically organized around a central ion pore.  Previous studies demonstrated that these subunits may serve as epitopes (antibody binding sites) in autoimmune disease.  By reversibly binding nAChR subunits, anti-nAChr antibodies may temporarily block the attachment site for ACh, resulting in muscle weakness.Researchers harvested muscle samples from mice to investigate the effects of anti-nAChR antibodies on muscle tension, the pulling force transmitted by muscles during contraction.Experiment 1First, skeletal muscle samples (tibialis anterior) of adult male mice were surgically harvested (n = 30), washed, and stripped of connective tissues.  Next, the isolated muscle samples were placed in a 150-mL oxygen-infused, electrolyte-rich bath containing glucose and Ca<sup>2+</sup> ions that were able to enter the muscle fibers and enable maximal contractile force.  One end of the submerged muscle was anchored in place while the other was attached to an apparatus that measures muscle tension and modifies muscle length.  Using electrodes, action potentials were elicited in the harvested muscle tissue to evaluate contractile function (Figure 1).    <strong>Figure 1</strong>  Action potential elicited from a harvested skeletal muscle sampleExperiment 2The researchers divided the 30 muscle samples into three groups of 10.  Resting muscle tension was measured, and the electrolyte-rich baths of each group were further infused with a 7.5-mL solution containing mouse-specific anti-nAChR antibodies, ACh, or a mixture of both (Table 1).  Post-infusion (peak) muscle tension was measured for 30 minutes, with results displayed in Figure 2.<strong>Table 1</strong>  Solutions Infused into the Electrolyte-Rich Bath      <strong>Figure 2</strong>  Pre-infusion resting muscle tension and post-infusion peak muscle tension in harvested muscle samples (Note: * indicates p < 0.05.) -In humans, skeletal muscles are innervated by the somatic nervous system and function to mediate: Figure 1  Action potential elicited from a harvested skeletal muscle sampleExperiment 2The researchers divided the 30 muscle samples into three groups of 10.  Resting muscle tension was measured, and the electrolyte-rich baths of each group were further infused with a 7.5-mL solution containing mouse-specific anti-nAChR antibodies, ACh, or a mixture of both (Table 1).  Post-infusion (peak) muscle tension was measured for 30 minutes, with results displayed in Figure 2.Table 1  Solutions Infused into the Electrolyte-Rich Bath Passage The nicotinic acetylcholine receptor (nAChR) is a protein embedded in the muscle fiber membrane that facilitates cell-to-cell communication across the neuromuscular junction.  When acetylcholine (ACh) binds nAChR, electrical depolarization within skeletal muscle fibers is induced and ultimately gives rise to contractile activity.  The nAChR is composed of five protein subunits symmetrically organized around a central ion pore.  Previous studies demonstrated that these subunits may serve as epitopes (antibody binding sites) in autoimmune disease.  By reversibly binding nAChR subunits, anti-nAChr antibodies may temporarily block the attachment site for ACh, resulting in muscle weakness.Researchers harvested muscle samples from mice to investigate the effects of anti-nAChR antibodies on muscle tension, the pulling force transmitted by muscles during contraction.Experiment 1First, skeletal muscle samples (tibialis anterior) of adult male mice were surgically harvested (n = 30), washed, and stripped of connective tissues.  Next, the isolated muscle samples were placed in a 150-mL oxygen-infused, electrolyte-rich bath containing glucose and Ca<sup>2+</sup> ions that were able to enter the muscle fibers and enable maximal contractile force.  One end of the submerged muscle was anchored in place while the other was attached to an apparatus that measures muscle tension and modifies muscle length.  Using electrodes, action potentials were elicited in the harvested muscle tissue to evaluate contractile function (Figure 1).    <strong>Figure 1</strong>  Action potential elicited from a harvested skeletal muscle sampleExperiment 2The researchers divided the 30 muscle samples into three groups of 10.  Resting muscle tension was measured, and the electrolyte-rich baths of each group were further infused with a 7.5-mL solution containing mouse-specific anti-nAChR antibodies, ACh, or a mixture of both (Table 1).  Post-infusion (peak) muscle tension was measured for 30 minutes, with results displayed in Figure 2.<strong>Table 1</strong>  Solutions Infused into the Electrolyte-Rich Bath      <strong>Figure 2</strong>  Pre-infusion resting muscle tension and post-infusion peak muscle tension in harvested muscle samples (Note: * indicates p < 0.05.) -In humans, skeletal muscles are innervated by the somatic nervous system and function to mediate: Passage The nicotinic acetylcholine receptor (nAChR) is a protein embedded in the muscle fiber membrane that facilitates cell-to-cell communication across the neuromuscular junction.  When acetylcholine (ACh) binds nAChR, electrical depolarization within skeletal muscle fibers is induced and ultimately gives rise to contractile activity.  The nAChR is composed of five protein subunits symmetrically organized around a central ion pore.  Previous studies demonstrated that these subunits may serve as epitopes (antibody binding sites) in autoimmune disease.  By reversibly binding nAChR subunits, anti-nAChr antibodies may temporarily block the attachment site for ACh, resulting in muscle weakness.Researchers harvested muscle samples from mice to investigate the effects of anti-nAChR antibodies on muscle tension, the pulling force transmitted by muscles during contraction.Experiment 1First, skeletal muscle samples (tibialis anterior) of adult male mice were surgically harvested (n = 30), washed, and stripped of connective tissues.  Next, the isolated muscle samples were placed in a 150-mL oxygen-infused, electrolyte-rich bath containing glucose and Ca<sup>2+</sup> ions that were able to enter the muscle fibers and enable maximal contractile force.  One end of the submerged muscle was anchored in place while the other was attached to an apparatus that measures muscle tension and modifies muscle length.  Using electrodes, action potentials were elicited in the harvested muscle tissue to evaluate contractile function (Figure 1).    <strong>Figure 1</strong>  Action potential elicited from a harvested skeletal muscle sampleExperiment 2The researchers divided the 30 muscle samples into three groups of 10.  Resting muscle tension was measured, and the electrolyte-rich baths of each group were further infused with a 7.5-mL solution containing mouse-specific anti-nAChR antibodies, ACh, or a mixture of both (Table 1).  Post-infusion (peak) muscle tension was measured for 30 minutes, with results displayed in Figure 2.<strong>Table 1</strong>  Solutions Infused into the Electrolyte-Rich Bath      <strong>Figure 2</strong>  Pre-infusion resting muscle tension and post-infusion peak muscle tension in harvested muscle samples (Note: * indicates p < 0.05.) -In humans, skeletal muscles are innervated by the somatic nervous system and function to mediate: Figure 2  Pre-infusion resting muscle tension and post-infusion peak muscle tension in harvested muscle samples (Note: * indicates p < 0.05.) -In humans, skeletal muscles are innervated by the somatic nervous system and function to mediate:

(Multiple Choice)
4.8/5
(70)

Passage At the blood-brain barrier, the cerebral spinal fluid (CSF) is separated from lymphatic circulation by epithelial cells bound by tight junctions.  Within the central nervous system (CNS), CSF surrounds and protects the brain and spinal cord and is believed to function in waste clearance for the CNS analogous to the role of the lymphatic system within the body.This waste clearance system has been dubbed the "glymphatic system."  Although the mechanism of clearance is largely unknown, specialized glial cells known as astrocytes appear to modify the interstitial volume between neurons.  This increase in interstitial volume allows for greater CSF flow, which increases the efficiency of neurotoxic clearance.  Waste products removed from the brain include metabolic products such as ammonia and harmful compounds such as amyloid proteins.Recent advances in imaging technology suggest that interstitial clearance may be modified during sleep.  To test this hypothesis, researchers indirectly studied changes in interstitial volume by measuring the percentage of CSF coverage in animal models during the first hour of sleep and again during the first hour of wakefulness (Figure 1). Passage At the blood-brain barrier, the cerebral spinal fluid (CSF) is separated from lymphatic circulation by epithelial cells bound by tight junctions.  Within the central nervous system (CNS), CSF surrounds and protects the brain and spinal cord and is believed to function in waste clearance for the CNS analogous to the role of the lymphatic system within the body.This waste clearance system has been dubbed the glymphatic system.  Although the mechanism of clearance is largely unknown, specialized glial cells known as astrocytes appear to modify the interstitial volume between neurons.  This increase in interstitial volume allows for greater CSF flow, which increases the efficiency of neurotoxic clearance.  Waste products removed from the brain include metabolic products such as ammonia and harmful compounds such as amyloid proteins.Recent advances in imaging technology suggest that interstitial clearance may be modified during sleep.  To test this hypothesis, researchers indirectly studied changes in interstitial volume by measuring the percentage of CSF coverage in animal models during the first hour of sleep and again during the first hour of wakefulness (Figure 1).    <strong>Figure 1.</strong>  Percentage of CSF coverage of interstitial space during sleep and wakefulness -Which of the following is true regarding the organization of neuronal tracts in the spinal cord? Figure 1.  Percentage of CSF coverage of interstitial space during sleep and wakefulness -Which of the following is true regarding the organization of neuronal tracts in the spinal cord?

(Multiple Choice)
4.9/5
(91)

Passage Eukaryotic organelles such as mitochondria and chloroplasts are believed to be relics of formerly free-living prokaryotes.  The transition from a hypoxic (low O2) to an oxic atmosphere (21% O2) is said to have enabled primitive eukaryotic anaerobes to engulf ancient aerobic prokaryotes and consequently acquire the ability to produce energy through oxidative phosphorylation.  This endosymbiotic theory of eukaryotic evolution also postulates that endosymbiosis resulted in larger eukaryotic genomes, which originated from the partial transfer of mitochondrial genes to the nuclear genome.  On integration into the host genome, mitochondria-derived genes became indistinguishable from the original nuclear genes.Researchers have alternatively proposed that after a prolonged period of symbiosis, there is a possibility of gene transfer from eukaryotes to prokaryotes.  This hypothesis was initially supported when copper/zinc (Cu/Zn) superoxide dismutase (SOD), a metalloprotein confined to the cytosol of eukaryotic cells, was found in Photobacterium leiognathi.  The free-living bacterium P. leiognathi is also a known symbiont of ponyfish, a small fish species native to the Indian and Pacific Oceans.SODs are antioxidant enzymes that serve as the cell's first line of defense against reactive oxygen species (ROS).  ROS produced by the electron transport chain damage proteins by oxidizing amino acid residues and metal ions on prosthetic groups, but can accumulate during times of biochemical and environmental stress.  Superoxide (O2−) radicals, a form of ROS, are sequestered by SODs and converted into less toxic hydrogen peroxide (H2O2) and O2 gas. Adapted from Bannister JV, Parker MW. The presence of a copper/zinc superoxide dismutase in the bacterium Photobacterium leiognathi: a likely case of gene transfer from eukaryotes to prokaryotes. Proc Natl Acad Sci USA. 1985;82(1):149-52. -Which observation would NOT support the hypothesis of gene transfer from eukaryotes to prokaryotes described in the passage?

(Multiple Choice)
4.9/5
(69)

Passage The lumen of the human gut is lined by a monolayer of epithelial cells that acts as a selectively permeable barrier, preventing the passage of harmful intraluminal foreign antigens, flora, and toxins into the circulation while allowing digestion and absorption of essential dietary nutrients along with the transfer of electrolytes and water.Proteins in the tight junctions of intestinal epithelial cells maintain barrier integrity, but barrier dysfunction occurs when these cells are damaged in the setting of infection, burns, shock, or hypoxia (low oxygen levels).  The transcription factor HIF-1, a heterodimer composed of the macromolecules HIF-1α and HIF-1β, regulates the adaptive cellular response to hypoxia and the consequent expression of tight junction proteins.Researchers assessed the concentration of HIF-1 heterodimer components in human intestinal Caco-2 cells subjected to hypoxia/reoxygenation (H/R) in vitro.  Caco-2 cells, a colon-derived cell line, were cultured under specific conditions to mimic the functional and morphological phenotype of wild-type enterocytes lining the small intestine.  These cells were prepared and grown as a monolayer on a collagen-coated membrane.Next, the monolayer was cultured in hypoxic conditions and then exposed to atmospheric oxygen levels (normoxia) for 30, 60, and 120 minutes.  Protein levels were quantified using direct enzyme-linked immunosorbent assay (ELISA), in which an antibody linked to a reporter enzyme was utilized to bind and detect expression of the target molecule (analyte) in a sample.  When the colorless substrate of the reporter enzyme was added, the enzyme generated a visible colored product that could be quantified based on color intensity. Passage The lumen of the human gut is lined by a monolayer of epithelial cells that acts as a selectively permeable barrier, preventing the passage of harmful intraluminal foreign antigens, flora, and toxins into the circulation while allowing digestion and absorption of essential dietary nutrients along with the transfer of electrolytes and water.Proteins in the tight junctions of intestinal epithelial cells maintain barrier integrity, but barrier dysfunction occurs when these cells are damaged in the setting of infection, burns, shock, or hypoxia (low oxygen levels).  The transcription factor HIF-1, a heterodimer composed of the macromolecules HIF-1α and HIF-1β, regulates the adaptive cellular response to hypoxia and the consequent expression of tight junction proteins.Researchers assessed the concentration of HIF-1 heterodimer components in human intestinal Caco-2 cells subjected to hypoxia/reoxygenation (H/R) in vitro.  Caco-2 cells, a colon-derived cell line, were cultured under specific conditions to mimic the functional and morphological phenotype of wild-type enterocytes lining the small intestine.  These cells were prepared and grown as a monolayer on a collagen-coated membrane.Next, the monolayer was cultured in hypoxic conditions and then exposed to atmospheric oxygen levels (normoxia) for 30, 60, and 120 minutes.  Protein levels were quantified using direct enzyme-linked immunosorbent assay (ELISA), in which an antibody linked to a reporter enzyme was utilized to bind and detect expression of the target molecule (analyte) in a sample.  When the colorless substrate of the reporter enzyme was added, the enzyme generated a visible colored product that could be quantified based on color intensity.    <strong>Figure 1</strong>  Concentration of (A) HIF-1α and (B) HIF-1β in Caco-2 cells subjected to H/R (Note:  0 minutes = cells cultured in hypoxic conditions)Emodin, an anthraquinone compound that prevents hypoxia-induced epithelial cell disruption, was used in conjunction with a chemical HIF-1α inhibitor (HIF-1α-I) to treat Caco-2 cells in a separate experiment.  Transepithelial electrical resistance (TEER) was assessed as a measure of barrier function, with higher TEER values indicating a more intact epithelial cell barrier.  HIF-1α-I was found to block emodin's protective effect on epithelial barrier integrity. Adapted from Lei Q, Qiang F, Chao D, et al. Int J Mol Med. 2014;34(6):1629-39. -When Caco-2 cells are cultured in hypoxic conditions, HIF-1 is most likely located in the: Figure 1  Concentration of (A) HIF-1α and (B) HIF-1β in Caco-2 cells subjected to H/R (Note:  0 minutes = cells cultured in hypoxic conditions)Emodin, an anthraquinone compound that prevents hypoxia-induced epithelial cell disruption, was used in conjunction with a chemical HIF-1α inhibitor (HIF-1α-I) to treat Caco-2 cells in a separate experiment.  Transepithelial electrical resistance (TEER) was assessed as a measure of barrier function, with higher TEER values indicating a more intact epithelial cell barrier.  HIF-1α-I was found to block emodin's protective effect on epithelial barrier integrity. Adapted from Lei Q, Qiang F, Chao D, et al. Int J Mol Med. 2014;34(6):1629-39. -When Caco-2 cells are cultured in hypoxic conditions, HIF-1 is most likely located in the:

(Multiple Choice)
4.7/5
(77)

Passage Hematological anomalies have been observed in patients with prolonged liver damage.  For example, patients with chronic cirrhosis (scarring of the liver) often develop anemia and other blood disorders.  Hemoglobin is the metalloprotein within red blood cells that is responsible for the oxygen-carrying capacity of blood, and its function may be affected by liver damage.  The poor prognosis of patients with cirrhosis and anemia has stimulated further study of hemoglobin function and oxygen saturation.Blood samples from both cirrhotic patients and healthy individuals at rest and after exercise were exposed to varying partial pressures of oxygen.  Measurement of oxyhemoglobin dissociation curves (ODCs [Figure 1]) from the blood samples revealed significant functional differences in the hemoglobin from cirrhotic patients relative to control subjects. Passage Hematological anomalies have been observed in patients with prolonged liver damage.  For example, patients with chronic cirrhosis (scarring of the liver) often develop anemia and other blood disorders.  Hemoglobin is the metalloprotein within red blood cells that is responsible for the oxygen-carrying capacity of blood, and its function may be affected by liver damage.  The poor prognosis of patients with cirrhosis and anemia has stimulated further study of hemoglobin function and oxygen saturation.Blood samples from both cirrhotic patients and healthy individuals at rest and after exercise were exposed to varying partial pressures of oxygen.  Measurement of oxyhemoglobin dissociation curves (ODCs [Figure 1]) from the blood samples revealed significant functional differences in the hemoglobin from cirrhotic patients relative to control subjects.    <strong>Figure 1</strong>  Oxyhemoglobin dissociation curve for cirrhotic patients (CP) at rest and for healthy controls (HC) at rest and after 20 minutes of exerciseVitamins are considered nontoxic supplements and are frequently provided to anemic patients to increase red blood cell production.  They may therefore have therapeutic benefits for cirrhotic patients.  However, some studies indicate that excessive vitamin consumption may lead to oxidative stress that could induce anemia through hemolysis (red blood cell rupturing).  Hemoglobin strongly absorbs light at 577 nm, and researchers conducted hemolysis assays by spinning down red blood cells and measuring absorbance (Abs) of the supernatant at 577 nm to determine how much hemoglobin was released.  The assay was carried out in the presence of four vitamins to determine their potential as oxidizing agents, and results are shown in Table 1.<strong>Table 1</strong>  Hemolysis of Red Blood Cells from Healthy Donors Treated With Vitamins [2 mM] for 30 Minutes, Measured by Absorbance at 577 nm    Adapted from Clerbaux T, Detry B, Geubel A, et al. The oxyhemoglobin dissociation curve in liver cirrhosis. Chest. 2006;129(2):438-45. -Individuals with glucose-6-phosphate dehydrogenase (G6PDH) deficiencies are more susceptible to oxidative stress than others.  If a patient with cirrhosis also suffered from G6PDH deficiency, which vitamin could cause the most severe reduction in that patient's hematocrit? Figure 1  Oxyhemoglobin dissociation curve for cirrhotic patients (CP) at rest and for healthy controls (HC) at rest and after 20 minutes of exerciseVitamins are considered nontoxic supplements and are frequently provided to anemic patients to increase red blood cell production.  They may therefore have therapeutic benefits for cirrhotic patients.  However, some studies indicate that excessive vitamin consumption may lead to oxidative stress that could induce anemia through hemolysis (red blood cell rupturing).  Hemoglobin strongly absorbs light at 577 nm, and researchers conducted hemolysis assays by spinning down red blood cells and measuring absorbance (Abs) of the supernatant at 577 nm to determine how much hemoglobin was released.  The assay was carried out in the presence of four vitamins to determine their potential as oxidizing agents, and results are shown in Table 1.Table 1  Hemolysis of Red Blood Cells from Healthy Donors Treated With Vitamins [2 mM] for 30 Minutes, Measured by Absorbance at 577 nm Passage Hematological anomalies have been observed in patients with prolonged liver damage.  For example, patients with chronic cirrhosis (scarring of the liver) often develop anemia and other blood disorders.  Hemoglobin is the metalloprotein within red blood cells that is responsible for the oxygen-carrying capacity of blood, and its function may be affected by liver damage.  The poor prognosis of patients with cirrhosis and anemia has stimulated further study of hemoglobin function and oxygen saturation.Blood samples from both cirrhotic patients and healthy individuals at rest and after exercise were exposed to varying partial pressures of oxygen.  Measurement of oxyhemoglobin dissociation curves (ODCs [Figure 1]) from the blood samples revealed significant functional differences in the hemoglobin from cirrhotic patients relative to control subjects.    <strong>Figure 1</strong>  Oxyhemoglobin dissociation curve for cirrhotic patients (CP) at rest and for healthy controls (HC) at rest and after 20 minutes of exerciseVitamins are considered nontoxic supplements and are frequently provided to anemic patients to increase red blood cell production.  They may therefore have therapeutic benefits for cirrhotic patients.  However, some studies indicate that excessive vitamin consumption may lead to oxidative stress that could induce anemia through hemolysis (red blood cell rupturing).  Hemoglobin strongly absorbs light at 577 nm, and researchers conducted hemolysis assays by spinning down red blood cells and measuring absorbance (Abs) of the supernatant at 577 nm to determine how much hemoglobin was released.  The assay was carried out in the presence of four vitamins to determine their potential as oxidizing agents, and results are shown in Table 1.<strong>Table 1</strong>  Hemolysis of Red Blood Cells from Healthy Donors Treated With Vitamins [2 mM] for 30 Minutes, Measured by Absorbance at 577 nm    Adapted from Clerbaux T, Detry B, Geubel A, et al. The oxyhemoglobin dissociation curve in liver cirrhosis. Chest. 2006;129(2):438-45. -Individuals with glucose-6-phosphate dehydrogenase (G6PDH) deficiencies are more susceptible to oxidative stress than others.  If a patient with cirrhosis also suffered from G6PDH deficiency, which vitamin could cause the most severe reduction in that patient's hematocrit? Adapted from Clerbaux T, Detry B, Geubel A, et al. The oxyhemoglobin dissociation curve in liver cirrhosis. Chest. 2006;129(2):438-45. -Individuals with glucose-6-phosphate dehydrogenase (G6PDH) deficiencies are more susceptible to oxidative stress than others.  If a patient with cirrhosis also suffered from G6PDH deficiency, which vitamin could cause the most severe reduction in that patient's hematocrit?

(Multiple Choice)
4.9/5
(77)

Certain turtle species exhibit embryonic expression of an enzyme that converts male sex hormones to female sex hormones.  The enzyme expression level determines whether a developing embryo will be male or female.  Scientists hypothesize that expression of this enzyme depends on incubation temperature during development.  To test this, they incubated 30 turtle eggs at 26°C and 30 eggs at 30°C and recorded the sex of each turtle after hatching (shown below). Certain turtle species exhibit embryonic expression of an enzyme that converts male sex hormones to female sex hormones.  The enzyme expression level determines whether a developing embryo will be male or female.  Scientists hypothesize that expression of this enzyme depends on incubation temperature during development.  To test this, they incubated 30 turtle eggs at 26°C and 30 eggs at 30°C and recorded the sex of each turtle after hatching (shown below).   Given this, the expression level of this enzyme in developing turtles is most likely: Given this, the expression level of this enzyme in developing turtles is most likely:

(Multiple Choice)
5.0/5
(67)
Showing 261 - 280 of 319
close modal

Filters

  • Essay(0)
  • Multiple Choice(0)
  • Short Answer(0)
  • True False(0)
  • Matching(0)